Reports

Disney saw robust growth in Q2 2025, led by strength in the Entertainment and Experiences segments. Adjusted EPS rose 20% year-over-year, and Direct-to-Consumer streaming subscribers increased. Net income returned to strong profitability compared to the prior-year loss.

• Revenue grew to $23.6 billion, up from $22.1 billion in Q2 2024.
• Net income hit $3.3 billion, reversing a net loss in the same period last year.

Arm delivered strong Q4 results with total revenue of $1.241 billion and record royalty and license revenues, driven by increasing deployment of Armv9 chips and AI demand across sectors.

• Total revenue reached a record $1.241 billion, up 34% YoY.
• Royalty revenue rose to $607 million, reflecting Armv9 and CSS chip demand.

Uber delivered a profitable quarter with $1.8 billion in net income and $2.3 billion in free cash flow. Revenue and trips grew double digits, reflecting continued platform strength in both Mobility and Delivery segments.

• Revenue reached $11.533 billion, up 14% year-over-year.
• Net income was $1.776 billion, reversing a loss in Q1 2024.

AppLovin delivered a robust first quarter with total revenue of $1.48 billion and net income of $576 million, largely driven by a 71% surge in advertising revenue. The company also announced the divestiture of its Apps business to focus more on its advertising platform.

• Total revenue grew to $1.48 billion, up from $1.06 billion a year ago.
• Advertising revenue soared by 71% year-over-year to $1.16 billion.

Emerson exceeded expectations on adjusted EPS and margins, supported by its operational excellence and AspenTech integration, despite lower GAAP EPS and compressed GAAP margins.

• Adjusted EPS grew to $1.48, surpassing expectations.
• Adjusted segment EBITA rose to $1.24B with a 28.0% margin, up from 26.0% last year.

Manulife's Q1 2025 showed solid core earnings of $1.8 billion, though overall net income declined to $485 million due to market-related losses. EPS dropped sharply, while core EPS rose modestly. The company posted record insurance sales and net flows in Global WAM, with strong segment contributions from Asia.

• Core earnings were $1.767 billion, supported by strong Asia and Global WAM performance.
• Net income fell to $485 million due to realized losses tied to the RGA U.S. Reinsurance transaction.

Johnson Controls delivered a strong Q2 with $5.676B in revenue, improved margins, and robust demand reflected in its record $14.0B backlog.

• Adjusted EPS reached $0.82, with GAAP EPS at $0.71.
• Revenue grew to $5.676B, with 7% organic growth.

Cencora delivered robust Q2 results with $75.5B in revenue and a significant boost in earnings. The company raised its full-year adjusted EPS guidance due to continued strength in the U.S. Healthcare Solutions segment.

• Revenue reached $75.5 billion, up 10.3% year-over-year.
• GAAP EPS increased to $3.68; Adjusted EPS was $4.42.

Vistra experienced a GAAP net loss of $268 million primarily due to unrealized mark-to-market losses on derivatives, but delivered strong adjusted EBITDA of $1.24 billion supported by robust retail and wholesale performance and contributions from the Energy Harbor acquisition.

• Q1 2025 GAAP net loss was $268 million, driven by unrealized derivative losses.
• Adjusted EBITDA from ongoing operations reached $1.24 billion, a 53% increase YoY.

Occidental delivered $860 million in adjusted income and $3.0 billion in operating cash flow before working capital. The company achieved mid-point production guidance and beat expectations in its OxyChem and Midstream segments.

• Generated $3.0B in operating cash flow before working capital.
• Delivered $860M in adjusted income with EPS of $0.87.

Axon reported strong Q1 2025 results with 31% year-over-year revenue growth led by software and services. Net income remained positive despite higher stock-based compensation, and the company raised its full-year revenue and EBITDA guidance.

• Quarterly revenue reached $604 million, growing 31% YoY.
• Net income was $88 million with a 14.6% margin.

Corteva reported higher operating EPS and net income in Q1 2025 driven by robust demand for its differentiated technology and operational efficiencies, despite a slight decline in GAAP revenue.

• Net income reached $667 million with GAAP EPS at $0.97 and operating EPS at $1.13.
• Organic sales increased by 3% despite a 2% drop in reported net sales due to currency impacts.

Verisk delivered solid Q1 2025 performance with $753M in revenue, $232M in net income, and strong operational execution driving both GAAP and non-GAAP EPS increases.

• Revenue reached $753M, up from $704M in Q1 2024.
• Net income increased to $232M, reflecting robust operational execution.

Rockwell Automation delivered solid operating performance in Q2 2025 despite a revenue decline. Profitability was supported by higher segment margins and cost management. Cash flow generation improved significantly year-over-year.

• Revenue declined 6% YoY to $2.001B, driven by lower volume and FX headwinds.
• Net income fell to $252M, with GAAP EPS at $2.22 and adjusted EPS at $2.45.

Carvana delivered a strong Q1 2025 with record-breaking revenue, net income, and adjusted EBITDA, supported by significant growth in retail vehicle sales and improved margins.

• Record Q1 revenue of $4.23 billion driven by 46% growth in retail unit sales.
• Net income reached an all-time Q1 high of $373 million with an 8.8% margin.

Texas Pacific Land Corporation delivered a robust Q1 2025 with record oil and gas royalty production and water segment revenues, resulting in solid earnings and free cash flow.

• Set a company record with oil and gas royalty production of 31.1 thousand Boe per day.
• Achieved record revenue of $69.4 million in the Water Services and Operations segment.

Barrick reported Q1 2025 revenue of $3.13B, EPS of $0.27 (adjusted EPS $0.35), and net income of $474M. Operating income reached $1.121B, driven by strong realized gold and copper prices, with free cash flow of $375M and robust liquidity of $4.1B in cash. Gold production was 758,000 oz and copper production 44,000 tonnes.

• Revenue grew to $3.13B, supported by higher gold and copper prices.
• Gold production of 758,000 oz was at the top end of guidance; copper production increased to 44,000 tonnes.

CDW began 2025 with a 6.7% year-over-year revenue increase and notable strength in its healthcare and education segments, maintaining stable margins despite economic uncertainty.

• Revenue rose to $5.2 billion, led by public sector demand, especially in healthcare and education.
• Adjusted EPS grew 11.9% to $2.15, reflecting strong operational execution.

Teva delivered $3.9 billion in revenue for Q1 2025, achieving its ninth consecutive quarter of growth. The company posted an adjusted EPS of $0.52 and generated $107 million in free cash flow, driven by innovative portfolio performance and effective cost management.

• Teva achieved its ninth straight quarter of revenue growth, totaling $3.9 billion.
• Innovative products generated $589 million and each grew more than 25% year over year.

Liberty Media's Formula One Group saw lower revenues and operating income in Q1 2025, attributed to one less race in the quarter and a different mix of events. Despite this, new sponsorship deals and an extended race calendar signal optimism for the rest of the year.

• Formula One Group revenue declined to $447 million from $587 million year-over-year.
• Only 2 F1 races were held in Q1 2025, compared to 3 in Q1 2024.

Atmos delivered strong Q2 FY25 results with growth in net income and EPS, driven by rate adjustments and customer growth, while maintaining robust capital investment in safety and reliability.

• Net income rose to $486 million, up from $432 million in the prior-year quarter.
• Diluted EPS for the quarter was $3.03, compared to $2.85 last year.

Trimble posted Q1 2025 revenue of $840.6M, driven by a record annualized recurring revenue and steady subscription services. Net income stood at $66.7M with an adjusted EPS of $0.61.

• Achieved record annualized recurring revenue of $2.18B
• Organic revenue grew 2% despite a 12% YoY revenue decline

NiSource delivered a robust Q1 2025 performance, achieving a net income of $474.8 million and maintaining its non-GAAP EPS guidance for the year.

• Reported GAAP net income of $474.8 million, up from $344.3 million in Q1 2024.
• GAAP EPS was $1.00; non-GAAP adjusted EPS was $0.98.

Owens Corning reported a 25% year-over-year increase in revenue to $2.53 billion, driven by strong performance across its segments and the integration of its newly acquired Doors business. The company maintained robust profitability with a 22% adjusted EBITDA margin and returned $159 million to shareholders.

• Revenue rose 25% YoY to $2.53B, including $540M from the new Doors business.
• Maintained 22% adjusted EBITDA margin for the 19th straight quarter.

CF Industries delivered solid Q1 2025 results, reporting $312 million in net income and $644 million in adjusted EBITDA on $1.66 billion in revenue, supported by increased production and higher nitrogen product prices.

• Net earnings rose to $312 million compared to $194 million in Q1 2024.
• Revenue reached $1.66 billion due to higher selling prices and production volumes.

Entegris posted Q1 2025 results in line with guidance, reporting modest revenue growth and solid adjusted earnings per share, driven by demand for CMP consumables and contamination control solutions.

• Net sales reached $773,200,000, up 0.3% year-over-year.
• Non-GAAP EPS was $0.67, within the company’s guidance.

Skyworks delivered Q2 2025 revenue of $953 million with GAAP EPS of $0.43 and non-GAAP EPS of $1.24, driven by a diversified portfolio and disciplined execution.

• Generated $410 million in cash flow from operations with a 43% margin.
• Returned over $600 million to shareholders via share repurchases and dividends.

Bentley Systems delivered a strong Q1 2025, achieving solid revenue growth and profitability driven by increased subscription revenues and sustained ARR expansion.

• Total revenue reached $370,542,000, driven by 11.5% YoY growth in subscriptions revenue.
• Net income rose to $91,368,000, translating to $0.28 per diluted share.

PFG achieved strong net sales growth of 10.5% and a 20.1% increase in Adjusted EBITDA for Q3 2025, although net income declined due to higher expenses tied to acquisitions and operational costs.

• Net sales rose 10.5% YoY to $15.3 billion, driven by acquisitions and case volume growth.
• Net income fell to $58.3 million, down 17.2% YoY due to increased expenses.

JLL reported Q1 2025 revenue of $5.75 billion, a 13% increase in local currency. Adjusted EPS rose 28% to $2.31, though net income declined to $55.3 million. Revenue growth was driven by solid performance across Leasing, Capital Markets, and Real Estate Management Services. However, bottom-line results were tempered by higher technology investments and equity losses.

• Revenue rose to $5.75 billion, up 13% in local currency, led by double-digit growth in both Resilient and Transactional revenues.
• Adjusted diluted EPS increased 28% to $2.31, while reported EPS dropped to $1.14 due to non-cash equity losses.

Curtiss-Wright achieved $806 million in Q1 revenue, driven by growth in all major segments, with adjusted operating income up 34% and record new orders totaling $1 billion.

• Sales rose 13% to $806 million with strength in defense and commercial markets.
• Adjusted operating income grew 34% to $134 million; adjusted margin reached 16.6%.

Houlihan Lokey reported record fiscal year 2025 revenues and strong fourth-quarter results across all three business segments, driven by favorable market conditions and increased transaction activity.

• Record Fiscal Year 2025 Revenues of $2.39 billion.
• Fourth Quarter Fiscal 2025 Revenues of $666 million, a 28% increase compared to the prior year.

Coherent delivered robust financial results in Q3 FY25, driven by continued AI-related datacenter demand and new product introductions. Revenue grew to $1.498 billion with significant gains in both GAAP and non-GAAP margins, and EPS turned positive on a non-GAAP basis.

• Record quarterly revenue of $1.498 billion, up 24% YoY
• Non-GAAP EPS surged to $0.91, up from $0.38 YoY

Bio-Techne delivered solid Q3 2025 results with 6% organic revenue growth and strong performance in its Protein Sciences segment. Adjusted EPS rose to $0.56, and the company achieved a 34.9% adjusted operating margin, supported by improved profitability and operational leverage.

• Q3 2025 revenue reached $316,181,000, up 6% organically year-over-year.
• Adjusted EPS increased to $0.56 from $0.48 a year ago.

Paycom Software posted $530.5M in revenue for Q1 2025 with net income of $139.4M. Adjusted EBITDA rose to $253.2M and the company raised its full-year outlook on the back of increased automation adoption and margin expansion.

• Revenue reached $530.5M, growing 6.1% year-over-year
• Adjusted EBITDA increased to $253.2M, with a margin of 47.7%

Liberty Broadband posted solid Q1 2025 results with revenue and operating income growth, largely supported by strength in GCI's business segment and improved cost management.

• Revenue rose to $266 million, up from $245 million in Q1 2024
• Net income attributable to shareholders reached $268 million

Dayforce delivered robust Q1 2025 performance with a 12% year-over-year revenue increase, net income more than doubling to $14.9 million, and notable gains in adjusted EPS and free cash flow.

• Total revenue reached $481800000, up 11.7% year-over-year.
• Net income rose to $14900000, more than double the $7100000 from Q1 2024.

Vaxcyte reported a net loss of $140.7 million for the first quarter of 2025, an increase from the $95.0 million net loss in the same period last year, primarily due to increased R&D and G&A expenses. The company ended the quarter with approximately $3.0 billion in cash, cash equivalents, and investments.

• Reported positive topline safety, tolerability, and immunogenicity data from the Phase 2 dose-finding study of VAX-24 in healthy infants.
• Initiated the second and final stage of the VAX-31 infant Phase 2 dose-finding study.

Permian Resources reported robust operational and financial results in Q1 2025, achieving record adjusted free cash flow of $460 million, maintaining strong production, and executing strategic acquisitions. The company also reinforced its balance sheet and returned capital to shareholders through dividends and share repurchases.

• Record adjusted free cash flow of $460 million and net income of $329.3 million
• Strong average daily production of 373,209 Boe/d, including 174,967 Bbls/d of oil

Tetra Tech posted record revenue and adjusted earnings in Q2 FY25, driven by strength in State, Local, U.S. Commercial, and International markets. The company navigated the termination of USAID contracts with strong performance, raised its FY25 EPS outlook, and expanded its capital return programs.

• Q2 revenue reached $1.322 billion, up 6% year-over-year
• Adjusted EPS grew 18% YoY to $0.33, beating guidance

Murphy USA posted a net income of $53.2 million in Q1 2025, down from $66.0 million in Q1 2024, due to higher store operating costs and interest expenses, which offset gains in fuel margins and merchandise contributions.

• Net income fell to $53.2 million, impacted by increased operating and interest expenses.
• Retail fuel contribution rose 7.1% to $267.7 million due to stronger margins despite lower volumes.

In Q2 2025, Amdocs generated $1.13 billion in revenue, down 9.4% as reported but up 4.0% on a pro forma constant currency basis. The company posted strong profitability and record managed services revenue, despite macroeconomic challenges.

• Revenue totaled $1.13 billion, reflecting a 9.4% YoY decline due to the phase-out of non-core business, but grew 4.0% on a pro forma constant currency basis.
• GAAP net income reached $164 million and GAAP EPS was $1.45, both above expectations.

Primerica reported $804.8 million in revenue and $169.1 million in net income for Q1 2025, driven by record Investment and Savings Products sales, growth in the life-licensed sales force, and steady performance in Term Life Insurance. Diluted EPS grew 19% year-over-year to $5.05.

• Total revenue increased 9% year-over-year to $804.8 million.
• Record $3.6 billion in Investment and Savings Product sales, up 28% year-over-year.

QIAGEN delivered a strong Q1 2025 performance with $483 million in revenue, 7% constant currency growth, and $0.55 adjusted EPS, surpassing guidance. Operating margins improved and a dividend initiation along with a $500M share repurchase program were announced.

• Net sales reached $483 million, up 5% year-over-year and 7% at constant exchange rates.
• Adjusted EPS was $0.55, above the guidance of at least $0.50.

The Middleby Corporation saw a 2.2% decline in revenue in Q1 2025, with adjusted EPS of $2.08 and net income of $92.4 million. Operating income improved modestly to $141 million. The company maintained strong cash generation and increased its share repurchase program.

• Revenue fell to $906.6 million, down from $926.9 million in Q1 2024.
• Adjusted EPS reached $2.08, while GAAP EPS was $1.69.

Royal Gold delivered record quarterly net income of $113.5 million and revenue of $193.4 million in Q1 2025, driven by favorable metal prices and solid stream and royalty contributions. The company maintained strong margins and liquidity, and increased its dividend payout.

• Recorded net income of $113.5 million and adjusted EPS of $1.51 for Q1 2025.
• Revenue reached $193.4 million, driven by 75% gold, 12% silver, and 9% copper sales.

Vertex delivered strong Q1 2025 results with a 12.9% increase in revenue, notable growth in cloud and subscription services, and a rise in net income. The company also maintained robust customer retention metrics and strategic investments in AI and acquisitions.

• Total revenue rose to $177.1 million, driven by 14.4% growth in software subscriptions and 29.6% in cloud revenue.
• Net income increased to $11.1 million, up from $2.7 million in the prior year.

The New York Times Company delivered a solid Q1 2025, led by 14.4% growth in digital-only subscription revenue and 12.4% growth in digital advertising revenue, with improved operating profit and net income.

• Digital-only subscription revenue rose 14.4% to $335 million.
• Digital advertising revenue increased 12.4% to $70.9 million.

Kyndryl reported $3.8 billion in Q4 revenue with net income of $68 million and adjusted EBITDA of $698 million. The company saw a significant improvement in adjusted pretax income, strong cash flow, and continued execution of its strategic initiatives. Kyndryl also provided a positive outlook for fiscal 2026.

• Q4 revenue was $3.8 billion, up 1.3% in constant currency; adjusted EBITDA rose 23% to $698 million.
• Net income of $68 million compared to a loss in the prior-year period; adjusted net income was $126 million.

Unity delivered $435M in revenue with a smaller net loss compared to Q1 2024, driven by cost discipline and strong early performance of Unity Vector.

• Revenue reached $435M, down 6% year-over-year due to portfolio reset.
• Net loss narrowed significantly to $78M from $291M a year earlier.

APA reported $2.64 billion in total revenue and $347 million in net income for Q1 2025. Adjusted earnings were $385 million, or $1.06 per share, and free cash flow reached $126 million. The company made operational progress across the Permian and Egypt and confirmed a significant discovery in Alaska.

• Net income attributable to common stock was $347 million, or $0.96 per diluted share
• Adjusted EBITDAX totaled $1.5 billion for the quarter

MarketAxess posted total revenue of $208.6 million and adjusted EPS of $1.87 for Q1 2025. GAAP net income plummeted due to a $54.9 million tax reserve, but operational performance remained resilient with record trading volumes across key segments.

• Revenue totaled $208.6 million, down 1% YoY, affected slightly by FX fluctuations.
• GAAP net income dropped to $15.1 million due to a $54.9 million reserve for uncertain tax positions.

Bruker delivered an 11.0% increase in revenue in Q1 2025, supported by acquisitions and moderate organic growth. Despite strong execution, the company reported a sharp decline in GAAP net income and EPS due to integration costs from 2024 acquisitions. Operating margin expanded on a non-GAAP basis thanks to proactive cost management. The company revised its FY2025 guidance downward due to academic market weakness and tariff impacts.

• Revenue rose 11.0% YoY to $801,400,000, including 2.9% organic growth.
• GAAP EPS dropped to $0.11, while non-GAAP EPS was $0.47.

Charles River Laboratories posted Q1 2025 revenue of $984.2M, down 2.7% YoY, with a GAAP EPS of $0.50 and non-GAAP EPS of $2.34. Despite lower revenue across all segments, non-GAAP operating margins improved due to cost-saving measures. The company raised its FY25 guidance slightly, citing improved DSA bookings.

• Q1 2025 revenue declined 2.7% YoY to $984.2 million, with organic revenue down 1.8%
• GAAP EPS dropped to $0.50 from $1.30; non-GAAP EPS rose to $2.34 from $2.27

IonQ posted a $32.3 million net loss despite achieving revenue above expectations. The company closed a $22M system deal with EPB and advanced its quantum networking roadmap through multiple acquisitions.

• Revenue for Q1 2025 was $7.6 million, slightly above the midpoint of guidance.
• IonQ posted a net loss of $32.3 million and an adjusted EBITDA loss of $35.8 million.

Genpact delivered $1.215 billion in revenue for Q1 2025, up 7.4% year-over-year. Net income was $131 million and adjusted EPS reached $0.84. Both operating and adjusted margins expanded, while free cash flow turned positive. The company remains focused on innovation and AI-led transformation to drive future growth.

• Revenue rose 7.4% year-over-year to $1.215 billion
• Data-Tech-AI revenue grew 11.1%, now 48% of total revenue

Axalta posted a solid Q1 2025 with adjusted EBITDA reaching a record $270 million. Despite a 3% decline in net sales due to currency headwinds and volume pressures, net income rose sharply to $99 million, and adjusted EPS reached $0.59. The company demonstrated resilience through cost management and strategic pricing.

• Net income jumped 154% YoY to $99 million, driven by reduced one-time expenses.
• Adjusted EBITDA reached a record $270 million with margin expansion to 21.4%.

Pan American Silver posted $773.2 million in revenue and $169.3 million in net income for Q1 2025. The company delivered $250.8 million in mine operating earnings, produced 5.0 million ounces of silver and 182.2 thousand ounces of gold, and generated $240.1 million in operating cash flow before working capital changes. Adjusted earnings reached $153.0 million, with free cash flow of $112.6 million.

• Revenue reached $773.2 million, up from $601.4 million YoY
• Generated $112.6 million in free cash flow and $240.1 million in operating cash flow before working capital

Light & Wonder delivered its 16th consecutive quarter of revenue growth, with expanded margins in all segments and solid cash flow. Net income remained flat, while adjusted EPS and free cash flow improved year-over-year.

• Revenue reached $774 million, a 2% increase from Q1 2024.
• Gaming segment revenue rose to $495 million, driven by broad-based growth.

Informatica exceeded Q1 2025 expectations with strong cloud subscription ARR growth of 30% YoY, improved operating margins, and robust cash flow. Total revenue rose nearly 4%, driven by cloud momentum and strategic product innovation.

• Cloud Subscription ARR grew 30% YoY to $848 million.
• Total revenue reached $403.9 million, up 3.9% YoY.

Blue Owl Capital Corporation posted Q1 2025 net investment income of $201.3 million and adjusted NII per share of $0.39. The company closed a major merger with OBDE, expanding total assets to over $18 billion. Portfolio yields remained strong amid continued floating rate exposure.

• Adjusted net investment income per share was $0.39, down from $0.47 in Q4 2024.
• Net asset value (NAV) per share declined slightly to $15.14 from $15.26.

H&R Block achieved a 4.2% year-over-year revenue increase in Q3 2025, with net income rising to $722.9 million and EPS hitting $5.32. The company maintained strong operating margins and reaffirmed its FY25 outlook.

• Revenue increased 4.2% year-over-year to $2.28 billion, driven by higher net average charge and increased U.S. return volume.
• Net income from continuing operations grew 4.5% to $722.9 million.

Revolution Medicines continued executing its clinical strategy in Q1 2025 with substantial R&D spend and new clinical data disclosures, while maintaining a strong cash position of $2.1 billion.

• Net loss increased to $213.4 million, up from $116.0 million year-over-year.
• Cash, cash equivalents and marketable securities totaled $2.1 billion.

MKS Instruments delivered solid Q1 2025 results, hitting the high end of revenue guidance with $936 million in sales, while net income reached $52 million and free cash flow totaled $123 million.

• Q1 revenue reached $936 million, led by growth in semiconductor and electronics markets.
• GAAP net income was $52 million, or $0.77 per diluted share.

BorgWarner's Q1 2025 results showed solid performance with $3.515 billion in revenue and strong adjusted EPS of $1.11. The company delivered a 10% adjusted operating margin, despite a decline in total net income and negative free cash flow. It also announced plans to exit its Charging business and secured major new business awards.

• Reported revenue of $3.515 billion, down 2% YoY.
• Adjusted EPS reached $1.11, up from $1.03 in Q1 2024.

Watts Water Technologies reported Q1 2025 results with revenue slightly down, but achieved record adjusted operating income and EPS through effective pricing, productivity, and cost actions.

• Revenue decreased 2% YoY to $558 million, impacted by fewer shipping days and European market softness.
• Adjusted diluted EPS reached a record $2.37, up from $2.33 in Q1 2024.

Jackson Financial delivered solid Q1 2025 results with $376 million in adjusted operating earnings, driven by growth in RILA assets and improved spread income, despite a GAAP net loss of $35 million due to hedging and reinsurance impacts.

• Adjusted operating earnings rose to $376 million, or $5.10 per diluted share.
• Net loss of $35 million due to reinsurance losses and unfavorable hedging impacts.

Lantheus delivered $372.8 million in revenue and $1.53 in non-GAAP EPS for Q1 2025, with strong free cash flow and continued strategic investments through acquisitions.

• Revenue reached $372.8 million, a 0.8% increase from Q1 2024.
• GAAP EPS dropped to $1.02 from $1.87 YoY, while adjusted EPS was $1.53.

Dutch Bros delivered a robust first quarter with 29% revenue growth, positive transaction momentum, and increased same shop sales, supported by expanding its shop footprint.

• Revenue increased 29.1% YoY to $355,152,000.
• Net income rose to $22,480,000 from $16,215,000 a year ago.

UGI Corporation posted robust second quarter earnings with adjusted diluted EPS rising 12% year-over-year, driven by colder weather and solid operational execution across all business segments.

• Adjusted diluted EPS increased to $2.21 from $1.97 in Q2 2024.
• Q2 GAAP diluted EPS was $2.19, compared to $2.30 in the prior-year quarter.

TPG delivered strong Q1 2025 results with increased revenue and net income, reflecting robust fundraising activity and expansion in fee-generating AUM.

• Revenue rose to $334 million, up from $312 million in Q1 2024.
• Net income increased to $54 million, a notable rise compared to $12 million in the prior year quarter.

Joby Aviation, Inc. issued its First Quarter 2025 Shareholder Letter, highlighting record certification progress for its electric air taxi, the appointment of Rodrigo Brumana as CFO, and a strong cash balance of $813 million. The company also became the first electric air taxi company to move to routine transition flights with a pilot onboard.

• Achieved record certification progress for the second consecutive quarter, reinforcing leadership in the sector.
• Became the first electric air taxi company to conduct routine transition flights with a pilot onboard, a critical step towards FAA flight testing.

Elanco Animal Health reported first quarter 2025 revenue of $1,193 million, a 1% decrease year-over-year but a 4% increase in organic constant currency. The company reported net income of $67 million and adjusted net income of $184 million. Reported EPS was $0.13 and adjusted EPS was $0.37. The company raised its full-year 2025 revenue guidance.

• First quarter 2025 revenue was $1,193 million, a 1% decrease year-over-year but a 4% increase in organic constant currency.
• Reported Net Income was $67 million, and Adjusted Net Income was $184 million.

Q2 Holdings, Inc. reported strong first quarter 2025 financial results with revenue of $189.7 million, a 15% increase year-over-year, and GAAP net income of $4.8 million, compared to a net loss in the prior year. Non-GAAP gross margin improved to 57.9% and adjusted EBITDA reached $40.7 million. The company signed five Tier 1 and Enterprise contracts and saw subscription annualized recurring revenue increase by 14% year-over-year.

• First quarter 2025 revenue was $189.7 million, a 15% increase year-over-year.
• GAAP net income for Q1 2025 was $4.8 million, a significant improvement from a net loss of $13.8 million in the prior-year quarter.

F&G Annuities & Life delivered a robust first quarter in 2025, with significant increases in net income and assets under management. The company's strategic focus on retail and institutional channels, coupled with effective capital deployment, contributed to its strong financial performance.

• Net income attributable to F&G Annuities & Life Inc. shareholders increased to $190 million, up from $100 million in the prior-year quarter.
• Assets Under Management (AUM) grew to $54.2 billion, marking a 20% increase year-over-year.

GXO Logistics reported a strong first quarter for 2025, with revenue increasing 21% year over year to $3 billion. Despite a net loss of $95 million, the company saw growth in adjusted EBITDA and organic revenue. They also grew their sales pipeline and secured significant new business wins, including a landmark contract with England's National Health Service Supply Chain. The company reaffirmed its full-year 2025 guidance for organic revenue growth and adjusted EBITDA.

• First quarter 2025 revenue increased 21% year over year to $3 billion.
• Organic revenue grew by 3% in the first quarter.

Kratos Defense & Security Solutions reported strong first quarter 2025 results with revenue growth of 9.2% year-over-year, driven by organic growth in both Unmanned Systems and Kratos Government Solutions segments. The company achieved a consolidated book-to-bill ratio of 1.2 to 1.0, indicating future revenue potential. Operating income and net income also saw increases compared to the prior year period.

• Total revenues for Q1 2025 were $302.6 million, a 9.2% increase from Q1 2024.
• GAAP Net Income attributable to Kratos was $4.5 million, resulting in GAAP EPS of $0.03.

Icahn Enterprises reported a net loss of $422 million for Q1 2025, compared to a loss of $38 million in Q1 2024. Adjusted EBITDA loss was $287 million, a significant increase from the $134 million loss in the prior year. The indicative net asset value decreased by $336 million from December 31, 2024, primarily due to losses in the Investment segment.

• Q1 2025 net loss attributable to IEP was $422 million, a substantial increase from the $38 million loss in Q1 2024.
• Adjusted EBITDA loss attributable to IEP was $287 million in Q1 2025, compared to a loss of $134 million in Q1 2024.

Cleveland-Cliffs Inc. reported a net loss of $483 million and an adjusted net loss of $456 million in Q1 2025, significantly impacted by underperforming non-core assets and lower index prices. The company is taking decisive action to idle six facilities, aiming for over $300 million in annual savings and a sharper focus on the automotive market.

• First-quarter 2025 revenues were $4.6 billion.
• GAAP net loss for Q1 2025 was $483 million, or $1.00 per diluted share.

Civitas Resources reported net income of $186 million and adjusted net income of $166 million for the first quarter of 2025, with crude oil, natural gas, and NGL revenues totaling $1.2 billion. The company generated $171 million in adjusted free cash flow and took strategic actions including launching a $100 million cost optimization initiative, adding commodity downside protection through hedging, and prioritizing net debt reduction in response to market volatility.

• Delivered disciplined start to the year prioritizing free cash flow generation and strengthening the balance sheet.
• Launched a $100-plus million cost optimization and efficiency initiative across the business.

Remitly Global reported a strong start to 2025, exceeding expectations for the first quarter with significant year-over-year growth in send volume, revenue, and a shift from a net loss to net income.

• First quarter 2025 revenue increased 34% year over year to $361.6 million.
• Send volume grew by 41% year over year, reaching $16.2 billion.

Verra Mobility delivered a strong first quarter in 2025 with key financial measures exceeding internal expectations, including total revenue of $223.3 million, net income of $32.3 million, and adjusted EBITDA of $95.4 million. The company reaffirmed its full-year 2025 guidance.

• Total revenue in Q1 2025 was $223.3 million, a 6% increase compared to Q1 2024.
• Net income for Q1 2025 was $32.3 million, or $0.20 per share.

SiTime reported strong revenue growth in Q1 2025, increasing 83% year-over-year to $60.3 million. The company reported a GAAP net loss of $23.9 million or $1.01 per diluted share, but a non-GAAP net income of $6.3 million or $0.26 per diluted share.

• Net revenue in the first quarter of 2025 was $60.3 million, an 83% increase compared to $33.0 million in the prior year quarter.
• GAAP gross profit was $30.3 million (50.3% of revenue), while non-GAAP gross profit was $34.6 million (57.4% of revenue).

GEO posted steady Q1 results with $604.6M in revenue and $19.6M in net income. While operating income declined YoY, the company made significant investments in ICE facility contracts, setting the stage for growth in H2 2025.

• Revenue held steady at $604.6M, nearly flat from Q1 2024.
• Net income was $19.6M with diluted EPS of $0.14.

RXO reported revenue of $1.4 billion and a GAAP net loss of $31 million for the first quarter of 2025. Adjusted EBITDA was $22 million. The company successfully migrated Coyote coverage operations to the RXO Connect platform and is raising its synergy estimate to greater than $70 million.

• Successful migration of Coyote coverage operations to the RXO Connect® platform completed.
• Raising synergy estimate to greater than $70 million of cash synergies.

Murphy Oil Corporation reported a net income of $73 million for the first quarter of 2025, with an adjusted net income of $81 million. The company made a second oil discovery in offshore Vietnam, repurchased $100 million in shares, and acquired a floating production storage and offloading vessel.

• Net income attributable to Murphy was $73 million, or $0.50 per diluted share.
• Adjusted net income attributable to Murphy was $81 million, or $0.56 per diluted share.

Black Hills Corp. reported stable first-quarter 2025 earnings per share compared to the prior year, benefiting from new rates, rider recovery, and favorable weather, which offset higher operating and financing costs. The company reaffirmed its full-year earnings guidance and highlighted progress on regulatory and growth initiatives, including a significant electric transmission expansion in Wyoming and efforts to secure new revenues in Nebraska and Kansas.

• Diluted EPS for Q1 2025 was $1.87, flat compared to Q1 2024.
• Revenue for Q1 2025 was $805.2 million, an increase from $726.4 million in Q1 2024.

Acushnet Holdings Corp. announced its first quarter 2025 financial results, with net sales of $703.4 million, a 0.6% decrease year-over-year but a 1.2% increase in constant currency. Net income attributable to Acushnet Holdings Corp. rose by 13.2% to $99.4 million, primarily due to a non-cash pre-tax gain of $20.9 million related to its FootJoy golf shoe joint venture. Adjusted EBITDA decreased by 9.6% to $138.9 million.

• First quarter net sales were $703.4 million, a 0.6% decrease year-over-year, but a 1.2% increase in constant currency.
• Net income attributable to Acushnet Holdings Corp. increased by 13.2% to $99.4 million, largely due to a non-cash pre-tax gain of $20.9 million from the FootJoy golf shoe joint venture deconsolidation.

Oscar Health saw substantial revenue growth driven by higher membership, accompanied by improved operating and net income margins.

• Total revenue grew to $3.05B, up significantly from $2.14B in Q1 2024.
• Net income rose to $275.3M, reflecting strong operational efficiency.

Ormat Technologies had a strong start to 2025, with increased revenue, net income, and adjusted EBITDA driven by improved performance in the Product and Storage segments. The Electricity segment saw a slight decline due to curtailments, but the company anticipates future growth from projects under development and a recent acquisition.

• Revenue increased by 2.5% in Q1 2025 compared to Q1 2024.
• Net income attributable to stockholders rose by 4.6% year-over-year.

ADMA Biologics reported a strong start to 2025 with total revenue increasing 40% year-over-year to $114.8 million and GAAP Net Income rising 51% to $26.9 million. Adjusted EBITDA saw an 81% increase to $47.9 million. The company also highlighted the FDA approval of its yield enhancement process and increased its full-year 2025 and 2026 guidance, alongside authorizing a $500 million share repurchase program.

• Strong Q1 2025 financial performance with significant year-over-year growth in revenue, net income, and adjusted EBITDA.
• FDA approval of the yield enhancement process expected to boost production output by 20% and support future growth and margin expansion.

Copa Holdings reported a net profit of US$176.8 million for the first quarter of 2025, a slight increase compared to the same period last year. Operating profit was US$213.8 million with an operating margin of 23.8%. Capacity (ASMs) increased by 9.5%, while Ex-fuel CASM decreased by 4.3% and RASM decreased by 8.1% year over year. The company ended the quarter with approximately US$1.3 billion in cash and investments.

• Net profit was US$176.8 million or US$4.28 per share, a US$0.7 million increase compared to 1Q24.
• Operating profit was US$213.8 million with an operating margin of 23.8%, a 1.0% and 0.4 percentage point decrease, respectively, compared to 1Q24.

BGC Group delivered record quarterly revenues of over $664 million, a 14.8% increase year-over-year, driven by robust organic growth in both Voice / Hybrid and Fenics businesses. FMX achieved its best quarter ever with record volumes and market share. The transformative acquisition of OTC Global Holdings is expected to add over $400 million in annualized revenue and be immediately accretive.

• Record quarterly revenues of $664.2 million, a 14.8% increase compared to the prior year's first quarter.
• Pre-tax Adjusted Earnings increased by 18.4% to $160.2 million.

Apellis Pharmaceuticals, Inc. experienced a decrease in total revenue to $166,797 thousand in Q1 2025 from $172,325 thousand in Q1 2024, primarily due to a decline in product revenue from SYFOVRE and EMPAVELI. The company's net loss increased to $92,225 thousand from $66,423 thousand in the prior year, driven by higher cost of sales and increased interest expense.

• Total revenue for Q1 2025 was $166,797 thousand, a decrease of 3% from Q1 2024.
• Net loss for Q1 2025 was $92,225 thousand, an increase of 39% from Q1 2024.

Kinetik reported solid first quarter 2025 results, exceeding internal estimates with a 7% year-over-year increase in Adjusted EBITDA driven by processed gas volume growth and margin expansion in the Midstream Logistics segment. The company progressed construction on the Kings Landing Complex and affirmed its 2025 Adjusted EBITDA and Capital Guidance ranges.

• Generated net income of $19.3 million and Adjusted EBITDA of $250.0 million for the first quarter of 2025.
• Achieved quarterly gas processed volumes of 1.80 Bcf/d, a 17% increase year-over-year.

ACV Auctions delivered robust performance in the first quarter of 2025, with revenue increasing by 25% year-over-year to $183 million and Adjusted EBITDA reaching $14 million, surpassing the high end of their guidance range. The company also saw significant growth in Marketplace and Service Revenue, Marketplace GMV, and Marketplace Units, indicating continued market share gains and traction with their dealer solutions.

• First quarter revenue increased 25% year-over-year to $183 million.
• Adjusted EBITDA for the first quarter was $14 million, exceeding the high end of guidance.

Rhythm Pharmaceuticals reported strong first quarter 2025 results with net product revenue from global sales of IMCIVREE reaching $37.7 million. The company achieved significant progress in its clinical trials, with the pivotal Phase 3 TRANSCEND trial for setmelanotide in acquired hypothalamic obesity meeting its primary endpoint, and regulatory submissions on track for Q3 2025. Additionally, the company's cash on-hand is expected to support operations into 2027.

• First quarter 2025 net product revenue from global sales of IMCIVREE was $37.7 million.
• The pivotal Phase 3 TRANSCEND trial for setmelanotide in acquired hypothalamic obesity met its primary endpoint with a -19.8% placebo-adjusted BMI reduction.

Perrigo's first quarter 2025 results showed a slight decline in net sales but significant growth in adjusted EPS and operating income, primarily due to the recovery of the infant formula business and benefits from Project Energize. The company reaffirmed its full-year financial targets despite widening net sales target ranges due to macroeconomic uncertainty.

• Net sales decreased 3.5% to $1.04 billion, primarily due to divested businesses, exited product lines, and currency translation.
• Adjusted diluted EPS increased 106.9% to $0.60, driven by higher adjusted operating income and lower interest expense.

StoneX Group reported a strong fiscal second quarter for 2025, with significant increases in net income and diluted EPS, driven by solid performance across various products and segments. Increased market volatility, coupled with strong client acquisition, helped offset the decline in short-term interest rates.

• Quarterly Net Operating Revenues increased by 15% to $487.3 million.
• Quarterly Net Income rose by 35% to $71.7 million.

Helmerich & Payne, Inc. reported net income of $1.7 million, or $0.01 per diluted share, on operating revenues of $1.0 billion for the fiscal second quarter ended March 31, 2025. The quarter was marked by the completion of the KCA Deutag acquisition, positioning the Company as a leading global drilling company, and continued strong performance in its North America Solutions segment.

• Completed the acquisition of KCA Deutag, a major milestone in the Company's long-term international growth strategy.
• Expects to realize in excess of $25 million in expense synergies from the KCA Deutag acquisition, with overall cost structure reduced by $50 to $75 million.

Howard Hughes Holdings Inc. delivered a strong first quarter in 2025, with net income from continuing operations at $10.8 million, a significant improvement from a loss in the prior year. Adjusted Operating Cash Flow reached $63 million, and Total Operating Assets Net Operating Income (NOI) hit a new quarterly record of $72 million, driven by strong performance in office and multifamily segments. The company also saw robust MPC EBT of $63 million, fueled by residential land sales, and secured significant capital infusion from Pershing Square to support future growth and diversification.

• Net income from continuing operations per diluted share was $0.21, a substantial improvement from a loss of $(0.42) in the prior-year period.
• Adjusted Operating Cash Flow reached $63 million, or $1.27 per diluted share, with full-year 2025 guidance unchanged at a mid-point of $350 million.

ESCO Technologies reported a strong second quarter for fiscal year 2025, with sales increasing by 7% to $266 million and GAAP EPS rising by 33% to $1.20. Adjusted EPS also saw significant growth, increasing by 24% to $1.35. The company achieved a record backlog of $932 million driven by a 22% increase in orders, resulting in a book-to-bill ratio of 1.10x.

• Q2 2025 sales increased 7% to $265.5 million compared to $249.1 million in Q2 2024.
• GAAP EPS increased 33% to $1.20 per share, and Adjusted EPS increased 24% to $1.35 per share.

Veracyte reported strong first quarter 2025 results driven by 22% total testing volume growth, leading to an 18% increase in total revenue to $114.5 million. Net income significantly improved to $7.0 million, and adjusted EBITDA grew 72% to $24.7 million.

• Total revenue increased 18% to $114.5 million in the first quarter of 2025.
• Total testing volume grew 22% to 40,655 tests, driven by strong Decipher and Afirma demand.

Hannon Armstrong (HASI) reported a solid first quarter in 2025, with managed assets increasing 12% year-over-year to $14.5 billion and recurring income up 14% year-over-year to $79 million. The company closed a record $700 million in transactions during the quarter and reaffirmed its Adjusted EPS growth guidance of 8-10% through 2027.

• Closed over $700 million in transactions during the quarter, setting a new Q1 record.
• Managed assets grew 12% year-over-year to $14.5 billion.

Avis Budget Group ended the first quarter of 2025 with revenues of $2.4 billion, a net loss of $505 million, and an Adjusted EBITDA loss of $93 million. The company recorded a non-cash fleet charge of $390 million related to the disposition of certain vehicles in the Americas as part of an accelerated fleet rotation strategy.

• Revenues for the first quarter of 2025 were $2.4 billion, a 5% decrease compared to the first quarter of 2024.
• The company reported a net loss attributable to Avis Budget Group, Inc. of $505 million for the first quarter of 2025, compared to a net loss of $114 million in the same period last year.

Marriott Vacations Worldwide reported a solid first quarter in 2025, with revenues excluding cost reimbursements increasing by 3% and Adjusted EBITDA growing by 3%. Net income attributable to common stockholders increased by 20% to $56 million, while adjusted net income attributable to common stockholders decreased by 9% to $65 million. The company reiterated its full-year Adjusted EBITDA outlook.

• Revenues excluding cost reimbursements increased by 3% year-over-year.
• Net income attributable to common stockholders was $56 million, a 20% increase from the prior year.

LifeStance Health Group, Inc. announced strong first quarter 2025 results, with revenue increasing 11% to $333.0 million and achieving a net income of $0.7 million, a significant improvement from a net loss in the prior year. The company also saw a 10% increase in its clinician base and visit volumes, contributing to its financial performance.

• Revenue increased 11% to $333.0 million compared to $300.4 million in Q1 2024.
• Net income reached $0.7 million, a substantial improvement from a net loss of $21.1 million in the prior year.

Acadia Pharmaceuticals reported a strong start to 2025 with total revenues of $244.3 million in the first quarter, representing a 19% year-over-year increase. Both NUPLAZID and DAYBUE product sales contributed to the growth, with NUPLAZID sales up 23% and DAYBUE sales up 11%. The company also highlighted progress in its pipeline, accelerating the timeline for the COMPASS PWS Phase 3 study results.

• Total revenues for the first quarter of 2025 were $244.3 million, a 19% increase year-over-year.
• NUPLAZID net product sales reached $159.7 million, growing 23% compared to the first quarter of 2024.

Brighthouse Financial, Inc. announced a net loss available to shareholders of $294 million, or $5.04 per diluted share, for the first quarter of 2025. However, adjusted earnings, less notable items, were $245 million, or $4.17 per diluted share. The company maintained a strong estimated combined risk-based capital ratio between 420% and 440% and holding company liquid assets of $1.0 billion.

• Net loss available to shareholders was $294 million, or $5.04 per diluted share.
• Adjusted earnings, less notable items, were $245 million, or $4.17 per diluted share.

Concentra reported a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter, driven by organic and inorganic growth, including the acquisition of Nova Medical Centers and the launch of new de novo centers.

• Revenue increased by 7.1% to $500.8 million in Q1 2025.
• Net income was $40.6 million, with earnings per common share of $0.30.

Steve Madden reported a slight increase in revenue for Q1 2025, reaching $553.5 million, with adjusted EPS of $0.60. The company completed the acquisition of Kurt Geiger, adding a new growth engine, but withdrew its financial guidance due to macroeconomic uncertainty and new tariffs.

• Revenue increased by 0.2% to $553.5 million compared to the same period in 2024.
• Adjusted diluted EPS was $0.60, slightly down from $0.65 in Q1 2024.

Symbotic delivered significant year-over-year revenue growth and enhanced its profitability metrics, highlighted by a substantial increase in adjusted EBITDA and gross profit, even as net losses persisted.

• Revenue grew to $549651000, up from $393332000 in Q2 2024.
• Net loss improved to $21438000 from $54830000 in the prior-year quarter.

Avista Corp. reported an increase in net income and diluted earnings per share for the first quarter of 2025 compared to the same period in 2024, driven by strong performance in Avista Utilities.

• Net income increased to $79 million in Q1 2025 from $71 million in Q1 2024.
• Diluted earnings per share rose to $0.98 in Q1 2025 from $0.91 in Q1 2024.

Kodiak Gas Services announced strong first quarter 2025 results, with record total revenues, adjusted EBITDA, and discretionary cash flow. The company saw increased operational efficiency and fleet utilization, leading to a sequential rise in Contract Services adjusted gross margin percentage. Kodiak also returned capital to shareholders through share repurchases and an increased quarterly dividend, while raising full-year 2025 guidance.

• Record quarterly adjusted EBITDA of $177.7 million.
• Contract Services adjusted gross margin percentage increased sequentially to 67.7%.

Alvotech reported a substantial increase in total revenues to $132.8 million in Q1 2025, up 260% from the previous year, and achieved a positive adjusted EBITDA of $20.5 million, a significant improvement from a negative $38.4 million in 2023. The company also raised its full-year guidance for top-line revenue and adjusted EBITDA.

• Total Revenues increased by 260% to $132.8 million in Q1 2025.
• Product Revenues surged by 786% to $109.9 million in Q1 2025.

Chesapeake Utilities Corporation reported a net income of $50.9 million for the first quarter of 2025, an increase from $46.2 million in the same period last year. Operating income also rose to $86.8 million from $79.6 million. Total operating revenues reached $298.7 million, up from $245.7 million, primarily due to increased customer consumption and growth in natural gas distribution businesses.

• Net income increased by $4.7 million to $50.9 million in Q1 2025 compared to Q1 2024.
• Operating income grew by $7.2 million to $86.8 million in Q1 2025.

American States Water Company's first quarter 2025 results showed a 13% increase in consolidated diluted earnings per share to $0.70, up from $0.62 in the prior year, largely benefiting from new rates at the water and electric utility segments. The company also highlighted significant authorized capital investments and consistent performance in its contracted services segment, despite some operational shifts and market impacts on retirement plan investments.

• Diluted EPS increased by 13% to $0.70, up from $0.62 in Q1 2024.
• New rates at regulated water and electric utilities were the primary driver of earnings growth.

Catalyst Pharmaceuticals delivered record first quarter 2025 total revenues of $141.4 million, a 43.6% year-over-year increase, driven by strong performance from FIRDAPSE and AGAMREE. The company ended the quarter with a strong balance sheet, including $580.7 million in cash and cash equivalents and no debt.

• Total revenues for Q1 2025 were a record $141.4 million, a 43.6% increase year-over-year.
• GAAP net income for Q1 2025 was $56.7 million, a 143.8% increase year-over-year.

LivaNova PLC announced robust first-quarter 2025 results, with revenue increasing by 7.4% on a reported basis and 10.4% organically. The company reported a GAAP diluted loss per share of $6.01 due to a significant environmental liability, but adjusted diluted earnings per share reached $0.88. Strong performance in Cardiopulmonary and Neuromodulation segments, along with key regulatory milestones for the aura6000™ System, contributed to the positive quarter.

• First-quarter revenue increased 7.4% reported, 8.9% constant-currency, and 10.4% organic, driven by strong demand and product rollout.
• Adjusted diluted earnings per share was $0.88, demonstrating operational efficiency despite a significant environmental liability.

FS KKR Capital Corp. experienced a decrease in net investment income and a significant decline in total net realized and unrealized gain (loss) in the first quarter of 2025 compared to the same period in 2024. The net increase in net assets resulting from operations also saw a notable reduction.

• Net investment income decreased from $212 million in Q1 2024 to $187 million in Q1 2025.
• Total net realized and unrealized gain (loss) shifted from a loss of $39 million in Q1 2024 to a loss of $67 million in Q1 2025.

Goodyear's first quarter 2025 net sales were $4.3 billion, with net income of $115 million, or $0.40 per share. The company reported $200 million in benefits from the Goodyear Forward plan and completed the sale of the Dunlop brand, further optimizing its portfolio and strengthening its balance sheet.

• First quarter 2025 net sales were $4.3 billion, with tire unit volumes totaling 38.5 million.
• Net income for Q1 2025 was $115 million ($0.40 per share), a significant improvement from a net loss of $57 million ($0.20 per share) in the prior year.

Crane NXT reported first quarter 2025 results with a 5% increase in sales year-over-year, reaching $330.3 million. Adjusted EPS was $0.54. The company completed the acquisition of De La Rue Authentication and increased its full-year sales growth guidance.

• Sales for Q1 2025 were $330.3 million, a 5.3% increase compared to Q1 2024.
• GAAP EPS was $0.38, and Adjusted EPS was $0.54 for the first quarter.

Azenta delivered a strong performance in an evolving and uncertain macroeconomic environment, with revenue up 5% year over year and adjusted EBITDA up 75% year over year, demonstrating the resilience of its portfolio.

• Revenue from continuing operations increased by 5% year over year to $143 million.
• Diluted EPS from continuing operations was ($0.40), while Non-GAAP diluted EPS from continuing operations was $0.05.

HNI Corporation delivered a solid start to 2025 with year-over-year growth in both revenue and earnings per share (non-GAAP). The company saw increased net sales driven by the Residential Building Products segment and improved non-GAAP operating margin.

• Net sales increased 2.0% year-over-year to $599.8 million.
• GAAP EPS was $0.29, a decrease of 21.6% year-over-year.

Coeur Mining, Inc. achieved a strong start to 2025 with a substantial increase in revenue to $360.1 million and a net income of $33.4 million, or $0.06 per diluted share. This performance was primarily fueled by higher gold and silver ounces sold, increased average realized prices for both metals, and the strategic acquisition of Las Chispas. The company also significantly reduced its debt and strengthened its liquidity.

• Revenue increased by 69% year-over-year to $360.1 million, driven by higher gold and silver sales volumes and prices.
• Net income reached $33.4 million, a significant improvement from a net loss of $29.1 million in the prior year period.

Semrush Holdings, Inc. reported first quarter 2025 revenue of $105.0 million, a 22% increase year-over-year. The company achieved an ARR of $424.7 million, up 20% year-over-year, and reported a non-GAAP operating margin of 11.6%. Net income attributable to Semrush Holdings, Inc. was $849 thousand, with basic and diluted EPS of $0.01.

• First quarter revenue increased by 22% year-over-year to $105.0 million.
• Annual Recurring Revenue (ARR) reached $424.7 million, growing 20% year-over-year.

Magnite reported a strong first quarter for 2025, exceeding top-line guidance for both CTV and DV+ Contribution ex-TAC. Revenue increased 4% year-over-year to $155.8 million, and Adjusted EBITDA grew significantly by 47% to $36.8 million, resulting in a 25% margin. The company posted a lower net loss compared to the prior year and achieved non-GAAP earnings per share of $0.12.

• Revenue grew 4% year-over-year to $155.8 million in Q1 2025.
• Adjusted EBITDA increased by 47% year-over-year to $36.8 million, with the margin expanding to 25%.

NCR Atleos reported strong first quarter 2025 results, with revenue of $980 million, GAAP net income of $17 million, and Non-GAAP diluted EPS of $0.64. Adjusted EBITDA grew 9% year-over-year to $175 million. The company reaffirmed its full year 2025 guidance.

• First quarter profit and earnings were at or above the high-end of guidance ranges.
• Revenue was $980 million, with 76% from recurring revenue streams.

Mirum Pharmaceuticals had a strong start to 2025 with commercial growth and pipeline advancements. Total revenue for Q1 2025 was $111.6 million, a significant increase from the same period in the previous year. The company also raised its full-year 2025 revenue guidance.

• First quarter 2025 total revenue reached $111.6 million.
• Full year 2025 revenue guidance was increased to $435 to $450 million.

CoreCivic reported strong first quarter 2025 financial results, exceeding internal expectations due to increased occupancy and new contracts, particularly with ICE. The company is reactivating three previously idle facilities and increasing its annual financial guidance.

• Total revenue for Q1 2025 was $488.6 million.
• Net income for Q1 2025 was $25.1 million, or $0.23 per diluted share.

Sunrun delivered a strong first quarter, surpassing volume and Cash Generation targets. The company reported a net income of $50.0 million and an EPS of $0.22. Key drivers included a record 69% storage attachment rate and successful securitization activities, contributing to positive Cash Generation for the fourth consecutive quarter.

• Aggregate Subscriber Value grew 23% year-over-year to $1.2 billion in Q1 2025.
• Contracted Net Value Creation increased 104% year-over-year to $164 million, or $0.72 per share.

OPENLANE, Inc. reported a strong start to fiscal year 2025, with a 7% increase in total revenue, driven by a 10% growth in the Marketplace segment. The company saw a significant increase in income from continuing operations and Adjusted EBITDA, along with robust cash flow generation.

• Revenue increased by 7% year-over-year to $460.1 million.
• Income from continuing operations grew by 99% year-over-year to $36.9 million.

Vishay Intertechnology reported first quarter 2025 revenues of $715.2 million, with a gross margin of 19.0%. The company experienced a net loss per share of ($0.03) and maintained a strong book-to-bill ratio of 1.08.

• Revenues for Q1 2025 were $715.2 million.
• Gross margin stood at 19.0%, impacted negatively by the addition of Newport.

AvidXchange reported a total revenue of $107.9 million for the first quarter of 2025, a 2.2% increase year-over-year. Despite this revenue growth, the company's GAAP net loss widened to $(7.3) million from $(1.0) million in the prior year. However, non-GAAP net income was $10.4 million, and adjusted EBITDA was $17.5 million.

• Total revenue increased by 2.2% year-over-year to $107.9 million in Q1 2025.
• GAAP net loss widened to $(7.3) million in Q1 2025, compared to $(1.0) million in Q1 2024.

EVERTEC reported a strong first quarter for 2025 with an 11% increase in revenue and a significant 105% increase in GAAP Net Income attributable to common shareholders. Adjusted EBITDA and Adjusted earnings per common share also saw double-digit growth. The company raised its full-year constant currency revenue and adjusted earnings per common share outlook.

• Revenue increased 11% year-over-year to $228.8 million.
• GAAP Net Income attributable to common shareholders increased 105% to $32.7 million.

Soleno Therapeutics reported a net loss of $43.8 million for the first quarter of 2025, compared to a net loss of $21.4 million in the same period of 2024. The company did not generate any revenue as commercialization of VYKAT XR had not commenced during this period. Operating expenses increased significantly, primarily due to increased selling, general and administrative costs in preparation for commercial launch.

• FDA approval of VYKAT XR for hyperphagia in adults and children four years of age and older with Prader-Willi syndrome (PWS) was announced.
• Patient treatments for VYKAT XR commenced on April 14, 2025, with 268 patient start forms received and 131 unique prescribers by May 6, 2025.

Innovative Industrial Properties (IIP) reported a decrease in total revenues to $71.7 million in Q1 2025 from $75.5 million in Q1 2024, primarily due to tenant defaults. Net income attributable to common stockholders also decreased to $30.3 million, or $1.03 per share. Despite these challenges, the company maintained strong liquidity and continued its portfolio management activities, including new leases and property sales.

• Total revenues for Q1 2025 were $71.7 million, a 5% decrease from Q1 2024, primarily driven by tenant defaults.
• Net income attributable to common stockholders was $30.3 million, or $1.03 per diluted share, down from $39.09 million, or $1.36 per diluted share, in Q1 2024.

Marqeta reported strong results for the first quarter of 2025, with significant growth in Total Processing Volume, Gross Profit, and Adjusted EBITDA, demonstrating improved profitability alongside business expansion.

• Total Processing Volume increased 27% year-over-year to $84 billion.
• Net Revenue grew 18% year-over-year to $139 million.

GoodRx reported a 3% increase in revenue and a significant improvement in net income for the first quarter of 2025 compared to the prior year, exceeding previous Adjusted EBITDA margin guidance. The company maintained its full-year 2025 revenue guidance and raised its Adjusted EBITDA expectations.

• Revenue for Q1 2025 increased 3% to $203.0 million compared to $197.9 million in Q1 2024.
• Net income for Q1 2025 was $11.1 million, a significant improvement from a net loss of $1.0 million in Q1 2024.

Kennametal announced its fiscal 2025 third quarter results, reporting sales of $486 million and diluted EPS of $0.41. Adjusted EPS was $0.47, exceeding the upper end of their outlook, primarily due to an advanced manufacturing production credit. The company returned approximately $40 million to shareholders through share repurchases and dividends.

• Sales decreased by 6% to $486 million from $516 million in the prior year quarter.
• Diluted EPS increased to $0.41 from $0.24 in the prior year quarter.

Geron Corporation reported $39.4 million in RYTELO net product revenue for Q1 2025, with total net revenue of $39.6 million. The company achieved approximately 85% enrollment in the Phase 3 IMpactMF clinical trial and received marketing authorization for RYTELO in the European Union.

• Reported $39.4 million in RYTELO net product revenue in Q1 2025, with demand relatively flat.
• Received marketing authorization for RYTELO from the European Commission (EC) and plans for commercial launch in select EU countries in 2026.

Amphastar Pharmaceuticals reported net revenues of $170.5 million for the first quarter of 2025, a slight decrease from the previous year, with GAAP net income of $25.3 million and adjusted non-GAAP net income of $36.9 million. The company highlighted strong growth in BAQSIMI® and Primatene MIST® sales, alongside progress in its biosimilar pipeline.

• Net revenues for Q1 2025 were $170.5 million.
• GAAP net income for Q1 2025 was $25.3 million, or $0.51 per share.

Fluence Energy reported a significant decrease in revenue and an increased net loss for the second quarter of fiscal year 2025 compared to the same period last year. The company also lowered its full year 2025 guidance, citing uncertainty in the U.S. market due to tariff policy.

• Total revenue for the quarter was $431.6 million, a 31% decrease year-over-year.
• GAAP net loss increased to $41.9 million from $12.9 million in the prior year quarter.

Schrödinger reported strong performance in the first quarter of 2025, with total revenue increasing 63% year-over-year to $59.6 million, driven by significant growth in both software and drug discovery segments. The company reported a GAAP net loss of $59.8 million and a non-GAAP net loss of $46.7 million for the quarter.

• Total revenue for Q1 2025 was $59.6 million, a 63% increase compared to Q1 2024.
• Software revenue grew 46% year-over-year to $48.8 million in Q1 2025.

Global Net Lease reported a revenue of $132.4 million and a net loss of $200.3 million for Q1 2025. The company successfully closed the first phase of its multi-tenant portfolio sale, generating $1.1 billion in gross proceeds and reducing net debt by $833.2 million. They also repurchased 7.9 million shares.

• Successfully closed the first phase of the multi-tenant portfolio sale, generating $1.1 billion in gross proceeds.
• Reduced Net Debt by $833.2 million in Q1 2025, improving Net Debt to Adjusted EBITDA from 8.4x to 6.7x.

Sonos reported Q2 Fiscal 2025 results, achieving revenue of $259.8 million, which was at the high end of their guidance range. The company also exceeded expectations for Adjusted EBITDA, reporting a loss of $0.8 million, significantly improved from the prior year, driven by substantial year-over-year expense reductions. GAAP net loss was $70.1 million and GAAP diluted EPS was ($0.58). Non-GAAP net loss was $21.7 million and Non-GAAP diluted EPS was ($0.18).

• Q2 revenue of $259.8 million was at the high end of the company's guidance range.
• Adjusted EBITDA of ($0.8) million exceeded expectations due to significant year-over-year expense declines.

Pitney Bowes announced strong financial results for the first quarter of 2025, with significant improvements in GAAP and Adjusted EPS and Net Income. The company also increased its quarterly dividend, reaffirmed full-year guidance, and outlined further cost reduction and deleveraging initiatives.

• Revenue was $493 million, a decrease of 5% year over year.
• GAAP EPS was $0.19, an improvement of $0.21 year over year.

Edgewell Personal Care reported a decrease in net sales and GAAP EPS for the second fiscal quarter of 2025 compared to the prior year. Gross margin increased, but operating income and net earnings declined. The company is maintaining an investment stance, focusing on brand equity and supporting innovation, while also updating its full-year outlook.

• Net sales were $580.7 million, a decrease of 3.1% compared to the prior year quarter.
• GAAP diluted EPS was $0.60, down from $0.72 in the prior year quarter.

PureCycle Technologies, Inc. reported its first quarterly revenues of $1.58 million for Q1 2025, a significant increase from no revenue in the prior year. The company achieved a net income of $8.832 million, a substantial improvement from a net loss of $85.607 million in Q1 2024, primarily driven by a decrease in the fair value of warrants and a gain from the Series A Preferred Stock put option. Operating loss improved to $(37.721) million from $(38.982) million year-over-year. The company continues to focus on improving commercial operating capabilities at its Ironton facility and pursuing project financing for the Augusta Facility.

• First quarterly revenues reported: PureCycle Technologies, Inc. generated $1.58 million in revenues for the first quarter of 2025, marking its initial period of meaningful operations and sales.
• Significant improvement in net income: The company achieved a net income of $8.832 million in Q1 2025, a substantial turnaround from a net loss of $85.607 million in Q1 2024.

CSG Systems International reported strong first quarter 2025 results with a 1.5% increase in total revenue to $299.5 million. Non-GAAP operating income and EPS saw significant increases compared to the prior year, driven by improved operating discipline and revenue mix. The company also reported strong cash flow from operations and the highest first-quarter non-GAAP adjusted free cash flow since 2018.

• Total revenue for Q1 2025 was $299.5 million, a 1.5% increase from Q1 2024.
• Non-GAAP adjusted operating margin expanded by over 240 basis points to 19.0% in Q1 2025 compared to 16.6% in Q1 2024.

Immunocore reported strong financial performance in the first quarter of 2025, driven by significant growth in KIMMTRAK net product sales. The company achieved profitability for the quarter and maintained a strong cash position to support ongoing clinical development programs.

• KIMMTRAK net product sales reached $93.9 million in Q1 2025, a 33% increase year-over-year.
• The company achieved a net income of $5.0 million for the quarter, a significant improvement from a net loss in the prior year period.

Horace Mann reported a strong first quarter in 2025 with significant increases in net income and core earnings compared to the prior year. Total revenue also saw a healthy increase.

• First-quarter net income reached $38.2 million, a 44.2% increase year-over-year.
• Core earnings for the quarter were $44.7 million, up 73.3% from the prior year.

DNOW Inc. exceeded first-quarter expectations with a 5% sequential revenue growth to $599 million and achieved its second-best first-quarter EBITDA of $46 million, despite a market with fewer operating rigs and completions. The company also made strategic capital allocation moves, including a key acquisition and share repurchases.

• Revenue for the first quarter of 2025 was $599 million, representing a 5% sequential growth.
• Net income attributable to DNOW Inc. was $22 million, or $0.20 per diluted share.

Alphatec Holdings, Inc. reported strong financial results for the first quarter of 2025, with total revenue increasing by 22% and surgical revenue growing by 24%. The company also raised its full-year revenue and profitability guidance.

• Total revenue reached $169 million in Q1 2025, a 22% increase year-over-year.
• Surgical revenue grew 24% to $152 million, driven by a 17% increase in procedural volume.

LandBridge Company LLC reported robust first quarter 2025 results, with revenues increasing 131% year-over-year to $44.0 million and net income reaching $15.5 million. Adjusted EBITDA also saw a substantial rise of 129% year-over-year to $38.8 million, demonstrating strong profitability and operational efficiency.

• Revenues increased by 131% year-over-year and 20% quarter-over-quarter, reaching $44.0 million.
• Net income for the quarter was $15.5 million, with a net income margin of 35%.

LegalZoom reported strong first-quarter 2025 results, exceeding the high end of their outlook range, driven by accelerating subscription growth and solid progress on strategic initiatives. Revenue increased 5% year-over-year to $183.1 million, and Adjusted EBITDA rose significantly by 33% to $37.0 million, expanding the margin to 20%. The company also delivered strong free cash flow and ended the quarter with a healthy cash balance.

• First quarter revenue reached $183.1 million, a 5% increase compared to the previous year.
• Subscription revenue grew by 8% year-over-year to $116.3 million, indicating progress in subscription growth initiatives.

Century Aluminum Company reported net sales of $633.9 million for the first quarter of 2025, a slight increase from the previous quarter. Net income attributable to Century stockholders decreased to $29.7 million, while adjusted EBITDA was $78.0 million.

• Net sales increased by $3.0 million sequentially to $633.9 million, driven by higher LME aluminum price, regional premium, and favorable volume and mix.
• Net income attributable to Century stockholders decreased by $15.5 million sequentially to $29.7 million, primarily due to higher input costs and losses on derivative instruments.

Fresh Del Monte Produce Inc. reported net sales of $1,098.4 million for the first quarter of 2025, a slight decrease from the prior year. Gross profit increased by 12% to $92.2 million, with gross margin expanding to 8.4%. The increase in gross profit was primarily driven by the fresh and value-added products segment.

• Net sales for Q1 2025 were $1,098.4 million, a decrease from $1,107.9 million in Q1 2024.
• Gross profit increased to $92.2 million in Q1 2025, up from $82.3 million in Q1 2024.

Marcus & Millichap reported improved results for the first quarter of 2025, with total revenue increasing by 12.3% compared to the same period in the prior year, driven by growth in both real estate brokerage commissions and financing fees. Despite a net loss, it was significantly reduced from the previous year.

• Total revenue for Q1 2025 was $145.0 million, a 12.3% increase from Q1 2024.
• Net loss improved to $4.4 million, or $0.11 per share, compared to a net loss of $10.0 million, or $0.26 per share in Q1 2024.

BrightView Holdings, Inc. experienced a decrease in net service revenues and net income for the three months ended March 31, 2025, compared to the same period in the prior year. However, the company saw an increase in Adjusted EBITDA, driven by cost management initiatives and increased snow removal services revenue. The Maintenance Services segment saw a revenue decrease due to strategic reductions in non-core businesses, while Development Services revenue increased due to higher project volumes.

• Net service revenues decreased by $10.3 million, or 1.5%, to $662.6 million.
• Net income decreased to $6.4 million from $33.7 million in the prior year.

Amplitude reported a return to double-digit revenue growth in Q1 2025, with revenue of $80.0 million, up 10% year-over-year. Annual Recurring Revenue reached $320 million, an increase of 12% year-over-year. The company's Non-GAAP operating loss improved slightly, and they announced a $50 million share repurchase program.

• First quarter revenue of $80.0 million, up 10% year-over-year.
• Annual Recurring Revenue was $320 million, up 12% year-over-year.

Fastly exceeded revenue and operating loss guidance in Q1 2025, achieving positive free cash flow. The company saw strong progress in go-to-market transformation, product velocity, and increased traffic share with large enterprise customers, leading to improved results.

• Total revenue reached $144.5 million, an 8% increase year-over-year.
• Generated $8.2 million in positive free cash flow, a significant improvement from a negative free cash flow in the prior year.

Vir Biotechnology reported a net loss of $120.965 million for Q1 2025, compared to a net loss of $65.276 million in Q1 2024. Total revenues decreased significantly to $3.032 million from $56.376 million in the prior year, primarily due to the expiration of GSK's rights. The company maintains a strong financial position with approximately $1.02 billion in cash and investments, providing a runway into mid-2027.

• Initiated Phase 3 registrational ECLIPSE program in chronic hepatitis delta with the first patient enrolled in Q1 2025, with the program receiving U.S. FDA Breakthrough and Fast Track designations and EMA PRIME and Orphan Drug designations.
• Continued dose escalation for PRO-XTEN™ dual-masked T-cell engagers VIR-5818 (HER2) and VIR-5500 (PSMA), with promising early Phase 1 safety profiles and no dose-limiting cytokine release syndrome observed.

Universal Technical Institute, Inc. (UTI) delivered a strong second quarter in fiscal year 2025, with revenue growing 12.6% year-over-year to $207.4 million and net income increasing 47.0% to $11.4 million. The company also saw significant growth in new student starts and average full-time active students, leading to raised full-year guidance for all key metrics.

• Revenue increased 12.6% to $207.4 million compared to the prior year.
• Total new student starts grew 21.4%, and average full-time active students increased 10.3%.

U.S. Physical Therapy, Inc. reported strong first quarter 2025 results with a significant increase in net income and revenue, primarily due to recent acquisitions and improved net patient revenue per visit, despite a Medicare rate reduction.

• Adjusted EBITDA increased by 16.5% to $19.5 million, driven by acquisitions and higher net patient revenue per visit.
• Net income attributable to USPH's shareholders increased by 23.75% to $9.9 million.

Veeco reported solid results in the first quarter of 2025 with revenue of $167.3 million. GAAP net income was $11.9 million, or $0.20 per diluted share, and non-GAAP net income was $22.2 million, or $0.37 per diluted share. The Semiconductor business saw sequential and year-over-year growth driven by Advanced Packaging.

• First quarter 2025 revenue was $167.3 million, a decrease from $174.5 million in the same period last year.
• GAAP net income for Q1 2025 was $11.9 million ($0.20 per diluted share), down from $21.9 million ($0.37 per diluted share) in Q1 2024.

Liberty Latin America experienced a net loss of $126.7 million and a revenue decrease of $15.9 million compared to the prior year. Despite this, the company saw an increase in operating income by $35.3 million and Adjusted OIBDA by $32.4 million. The company's financial condition was impacted by various factors including foreign currency exchange rates, interest rates, and acquisition-related adjustments.

• Net loss for the quarter was $126.7 million, compared to a net loss of $0.5 million in the prior year.
• Revenue decreased by $15.9 million to $1,083.5 million, primarily due to organic declines and foreign currency impacts.

Teekay Tankers reported its results for the first quarter of 2025 and declared both a fixed and a special cash dividend.

• Teekay Tankers released its earnings results for the quarter ended March 31, 2025.
• The Board of Directors declared a fixed cash dividend of $0.25 per share.

QuinStreet, Inc. announced robust financial results for the fiscal third quarter ended March 31, 2025, with revenue increasing by 60% year-over-year to $269.8 million. The company also reported adjusted EBITDA of $19.4 million and generated $30.1 million in operating cash flow, ending the quarter with $81.8 million in cash and no bank debt.

• Revenue increased by 60% year-over-year to $269.8 million in Q3 FY25.
• Adjusted EBITDA reached $19.4 million, marking a 145% increase year-over-year.

RxSight, Inc. reported strong first quarter 2025 results with significant revenue growth driven by increased sales of Light Adjustable Lenses and Light Delivery Devices. The company reiterated its full-year 2025 guidance.

• Total revenue for Q1 2025 was $37.9 million, a 28% increase compared to Q1 2024.
• Light Adjustable Lens (LAL) procedure volume increased by 36% in Q1 2025 compared to the prior year period.

Kennedy-Wilson Holdings, Inc. reported a net loss of $40.8 million for Q1 2025, a decrease from a net income of $26.9 million in Q1 2024. However, Adjusted EBITDA increased by 5% to $98.2 million, driven by higher property NOI and a 17% increase in investment management fees to $25 million. The company deployed or committed approximately $1 billion of capital in Q1 and expects to generate over $400 million from non-core asset sales in the remainder of 2025.

• Net loss attributable to common shareholders was $40.8 million, compared to net income of $26.9 million in Q1 2024.
• Adjusted EBITDA increased by 5% to $98.2 million, up from $203.2 million in Q1 2024.

Sabre's first quarter 2025 financial performance was in line with guidance, with revenue of $777 million and operating income of $103 million. The company also announced an agreement to sell its Hospitality Solutions business for $1.1 billion, with net cash proceeds primarily intended for debt repayment.

• Financial performance aligned with Q1 guidance, reaffirming FY'25 outlook for double-digit YoY distribution bookings growth and high single-digit YoY revenue growth.
• Entered into an agreement to sell Hospitality Solutions business for $1.1 billion, with plans to use $960 million net cash proceeds to repay debt.

Centrus Energy Corp. reported a strong first quarter in 2025, achieving significant net income and revenue growth compared to the prior year. The company also retired its higher-interest rate debt, resulting in a gain.

• Net income for Q1 2025 was $27.2 million, a significant improvement from a net loss of $6.1 million in Q1 2024.
• Total revenue for Q1 2025 was $73.1 million, an increase of 67% compared to $43.7 million in Q1 2024.

Sitio Royalties delivered strong first quarter 2025 results, exceeding production guidance and reporting increased net income and Adjusted EBITDA compared to the prior year. The company continued its focus on returning capital to shareholders through dividends and share repurchases, and authorized an additional $300 million for share buybacks.

• First quarter 2025 total average daily production of 42.1 MBoe/d exceeded the high end of the full year guidance range.
• Net wells turned-in-line increased by 34% quarter-over-quarter.

Sezzle Inc. announced robust first quarter 2025 financial results, driven by increased subscriber engagement and consumer purchase frequency. The company reported a 123.3% year-over-year increase in total revenue to $104.9 million and a 260.6% increase in operating income to $49.9 million. Net income more than quadrupled to $36.2 million, leading to a significant raise in its 2025 net income guidance to $120 million.

• Gross Merchandise Volume (GMV) reached $808.7 million in 1Q25, a 64.1% YoY increase, driven by higher subscriber and on-demand user engagement.
• Total Revenue grew 123.3% YoY to a new quarterly high of $104.9 million, with Total Revenue as a percentage of GMV rising to 13.0%.

AMC Entertainment Holdings, Inc. reported total revenues of $862.5 million for the first quarter of 2025, a decrease from $951.4 million in Q1 2024. The company's net loss widened to $(202.1) million from $(163.5) million in the prior year, and Adjusted EBITDA was $(58.0) million, down from $(21.2) million. Despite a challenging Q1, the company expressed optimism for the remainder of 2025 and 2026, citing a strong slate of upcoming blockbusters and booming movie theatre demand since April 1.

• Total revenues for Q1 2025 were $862.5 million, a decrease of 9.3% from Q1 2024.
• Net loss for Q1 2025 was $(202.1) million, compared to a net loss of $(163.5) million in Q1 2024.

Roots experienced a decline in total sales and net income in Q1 2024 compared to the previous year, primarily due to lower off-price sales and a disciplined inventory management approach. Despite this, the company saw an increase in DTC gross margin, improved free cash flow, and a significant reduction in net debt.

• Total sales decreased by 9.7% to $37.5 million in Q1 2024 from $41.5 million in Q1 2023.
• Net income (loss) was ($8.9) million, compared to ($8.0) million in Q1 2023.

STAAR Surgical reported net sales of $42.6 million for the first quarter of 2025, a 45% decrease year-over-year, primarily due to a planned reduction of channel inventory in China. The company incurred a net loss of $(54.2) million and an adjusted EBITDA loss of $(26.4) million. Despite the challenges in China, sales excluding China increased by 9% year-over-year.

• Net sales decreased by 45% year-over-year to $42.6 million, driven by a planned reduction of channel inventory in China.
• Sales excluding China increased by 9% year-over-year, reflecting growth in all key markets outside of China.

Tutor Perini reported strong results for the first quarter of 2025 with significant year-over-year growth in revenue, income from construction operations, and diluted EPS. The company achieved a record backlog and substantially reduced total debt.

• Revenue for Q1 2025 was $1.25 billion, an increase of 19% compared to Q1 2024.
• Income from construction operations for Q1 2025 was $65.3 million, up 34% year-over-year.

DXP Enterprises reported strong first quarter results for 2025, with a significant increase in sales and net income compared to the previous year. The company saw growth across all its business segments, driven by both organic growth and recent acquisitions.

• Sales increased 15.5% year-over-year to $476.6 million.
• GAAP diluted EPS rose to $1.25 from $0.67 in the prior year.

Taboola reported strong first-quarter 2025 financial results, with revenues of $427.5 million, a 3% increase year-over-year, and a significant 53% increase in Adjusted EBITDA to $36 million, driven by ad spend growth and cost discipline.

• Revenues increased by 3% to $427.5 million, primarily due to 9% growth in Scaled Advertisers.
• Gross Profit rose by 10% to $119.3 million, and ex-TAC Gross Profit increased by 9% to $152 million.

Encore Capital Group, Inc. reported a strong start to 2025, with consolidated financial results for the first quarter showing significant growth across key metrics. Global portfolio purchases increased by 24% to $368 million, and global collections rose by 18% to $605 million. Net income more than doubled, leading to a 103% increase in earnings per share to $1.93.

• Global portfolio purchases increased 24% to $368 million, including a record $316 million in U.S. purchases.
• Global collections grew 18% to $605 million, with U.S. collections reaching a record $454 million.

Innoviva reported a net loss of $46.6 million in the first quarter of 2025, primarily due to unfavorable changes in investment values. However, the company's core royalty platform maintained strong performance, net product sales increased significantly by 59% year-over-year driven by a 52% increase in U.S. product sales, and income from operations grew by 61%.

• Core royalty platform generated $61.3 million in gross revenue in Q1 2025.
• Innoviva Specialty Therapeutics achieved U.S. net product sales of $26.4 million, reflecting 52% year-over-year growth.

ProFrac Holding Corp. announced strong first quarter 2025 results, with total revenue increasing to $600 million and Adjusted EBITDA rising to $130 million, reflecting improved operating efficiency and higher volumes in Proppant Production.

• Total revenue increased by 32% to $600 million in Q1 2025 compared to $455 million in Q4 2024.
• Adjusted EBITDA surged by 83% to $130 million in Q1 2025 from $71 million in Q4 2024, representing 22% of revenue.

Generation Bio reported a net loss of $14.8 million for Q1 2025, an improvement from the $74.5 million net loss in Q1 2024. The company's cash position remains strong at $157.6 million, expected to fund operations into the second half of 2027, and it continues to advance its cell-targeted lipid nanoparticle (ctLNP) technology for autoimmune diseases.

• Generation Bio is advancing its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its ctLNP technology.
• The company's cash balance was $157.6 million as of March 31, 2025, projected to fund operations into the second half of 2027.

Ellington Financial Inc. reported net income of $0.35 per common share and adjusted distributable earnings of $0.39 per common share for the first quarter of 2025, driven by strength in mortgage loan portfolios and securitization activities, despite market volatility.

• Net income attributable to common stockholders was $31.6 million, or $0.35 per common share.
• Adjusted Distributable Earnings were $35.5 million, or $0.39 per common share.

BBSI delivered a strong start to the year with revenues up 10% to $292.6 million and gross billings up 9% to $2.09 billion. The company reported a net loss of $1.0 million, or $(0.04) per diluted share, which was attributed to seasonality in payroll tax expense.

• Revenues increased 10% to $292.6 million in Q1 2025 compared to $265.8 million in Q1 2024.
• Gross billings grew 9% to $2.09 billion in Q1 2025, up from $1.91 billion in Q1 2024.

Digi International reported its second fiscal quarter 2025 results, showing a decrease in revenue but significant increases in net income and adjusted EBITDA, driven by improved gross profit margins and strong cash generation. The company also saw a notable increase in Annualized Recurring Revenue (ARR) and reduced its outstanding debt.

• Revenue for Q2 2025 was $105 million, a 3% decrease compared to Q2 2024.
• Net income for Q2 2025 was $10 million, a significant increase from $4 million in Q2 2024.

Fiverr delivered strong Q1 results, surpassing revenue and adjusted EBITDA expectations. Growth was driven by robust services revenue, steady marketplace performance, and increasing traction from Fiverr Go and Fiverr Pro initiatives.

• Revenue grew 14.6% year-over-year to $107.18M, exceeding guidance midpoint.
• GAAP Net Income was $798,000, or $0.02 per share; Non-GAAP EPS was $0.64.

Bloomin' Brands reported a decrease in total revenues primarily due to restaurant closures and a decrease in comparable restaurant sales. Despite a challenging macro environment, the company is focusing on operational priorities to simplify the business and drive sustainable sales and profit growth.

• Total revenues decreased by 1.8% to $1,049.6 million in Q1 2025 compared to Q1 2024.
• Diluted EPS from continuing operations was $0.50, a significant improvement from $(1.00) in Q1 2024.

Turning Point Brands reported strong first quarter 2025 results with net sales increasing 28.1% year-over-year to $106.4 million, driven by substantial growth in Modern Oral sales. Net income rose by 19.8% to $14.4 million, and adjusted EBITDA increased by 12.0% to $27.7 million.

• Net Sales for Q1 2025 increased 28.1% year-over-year to $106.4 million.
• Modern Oral Net Sales for Q1 2025 reached $22.3 million, nearly 10-times higher than the prior year.

AOS reported fiscal Q3 2025 results at the high-end of guidance, with revenue of $164.6 million, a 9.7% increase year-over-year. The company experienced strength in Computing and better-than-expected demand in tablets, despite a seasonal decline from the prior quarter. Both GAAP and non-GAAP gross margins decreased compared to the prior quarter and the same quarter last year. The company posted a GAAP net loss of $10.8 million and a non-GAAP net loss of $2.9 million.

• Revenue for fiscal Q3 2025 was $164.6 million, up 9.7% year-over-year.
• GAAP gross margin was 21.4%, down from 23.7% in the same quarter last year.

Armada Hoffler Properties, Inc. announced a net loss of $(0.07) per diluted share for the first quarter of 2025, a decrease from a net income of $0.17 per diluted share in the same period last year. Funds from operations (FFO) decreased to $0.17 per diluted share from $0.40, and Normalized FFO decreased to $0.25 per diluted share from $0.33. The company maintained its 2025 full-year Normalized FFO guidance range of $1.00 to $1.10 per diluted share.

• Net loss attributable to common stockholders and OP Unit holders was $7.2 million, or $(0.07) per diluted share, compared to net income of $14.8 million, or $0.17 per diluted share, for Q1 2024.
• Normalized FFO was $25.6 million, or $0.25 per diluted share, a decrease from $29.4 million, or $0.33 per diluted share, for Q1 2024.

Forward Air Corporation reported improved financial results in the first quarter of 2025 compared to the prior year, with consolidated revenue increasing by 13.2% to $613.3 million. The company saw a significant improvement in income from operations, moving from a loss of $65.7 million in Q1 2024 to a profit of $4.8 million in Q1 2025. Net loss also narrowed from $88.8 million to $61.2 million.

• Consolidated revenue for Q1 2025 was $613.3 million, a 13.2% increase year-over-year.
• Income from operations improved significantly to $4.8 million in Q1 2025 compared to a $65.7 million loss in Q1 2024.

Sinclair reported a decrease in total revenues and net income for the first quarter of 2025 compared to the prior year period. The company experienced a net loss of $156 million and saw decreases in media revenues and operating income. Adjusted EBITDA also declined.

• Total revenues decreased 3% to $776 million compared to $798 million in the prior year period.
• Net loss attributable to the Company was $156 million versus net income of $23 million in the prior year period.

Nextdoor Holdings, Inc. reported a net loss of $21.952 million for the three months ended March 31, 2025, a 22% decrease from the $28.261 million net loss in the same period last year. Revenue increased by 2% to $54.176 million, driven by increased user engagement. Total costs and expenses decreased by 8% to $81.189 million.

• Net loss decreased by 22% to $21.952 million, indicating improved financial efficiency.
• Revenue increased by 2% to $54.176 million, primarily due to increased user engagement.

Phibro Animal Health Corporation delivered strong financial results for the third quarter of fiscal year 2025, with net sales increasing by 32% and net income surging by 148% compared to the same period last year. The growth was primarily driven by the acquisition of Zoetis's medicated feed additive portfolio, which significantly boosted Animal Health segment revenues.

• Net sales increased by 32% to $347.8 million, primarily due to the acquisition of Zoetis's MFA portfolio.
• Net income grew by 148% to $20.88 million, reflecting improved operating performance.

Radware started 2025 with strong first quarter results, achieving 11% year-over-year revenue growth and significant non-GAAP EPS growth, reflecting high leverage in its business model.

• Revenue increased by 11% year-over-year to $72.1 million.
• Non-GAAP diluted EPS rose to $0.27, up from $0.16 in Q1 2024.

National Vision Holdings, Inc. delivered strong first quarter 2025 results with a 5.7% increase in net revenue to $510.3 million and a 21.8% increase in Adjusted Operating Income to $41.3 million. The company also reported a 4.1% comparable store sales growth and raised its fiscal 2025 outlook.

• Net revenue from continuing operations increased by 5.7% to $510.3 million.
• Comparable store sales growth was 4.1%, marking the 9th consecutive quarter of positive growth.

Trinity Capital Inc. announced robust financial results for the first quarter ended March 31, 2025, with total investment income increasing by 29.5% year-over-year to $65.4 million. Net investment income reached $32.4 million, or $0.52 per basic share, and the net asset value hit a new high of $833.4 million. The company also reported a 15.5% return on average equity.

• Total investment income grew by 29.5% year-over-year, reaching $65.4 million.
• Net investment income was $32.4 million, translating to $0.52 per basic share.

Bumble reported a decrease in total revenue and Bumble App revenue in the first quarter of 2025 compared to the prior year period. Total paying users remained relatively flat, while Bumble App paying users slightly decreased.

• Total Revenue decreased by 8% to $247.1 million.
• Bumble App Revenue decreased by 6% to $202 million.

Establishment Labs reported a 11.3% increase in revenue to $41.4 million in Q1 2025 compared to the prior year, primarily driven by strong U.S. sales. Despite the revenue growth, the company experienced increased operating expenses, resulting in a higher net loss and adjusted EBITDA loss compared to Q1 2024. The cash balance at the end of the quarter was $69.2 million.

• Worldwide revenue for Q1 2025 was $41.4 million, an increase from $37.2 million in Q1 2024.
• Gross margin improved to 67.2% in Q1 2025 from 65.6% in the prior year period.

Hagerty, Inc. announced a robust start to 2025, with first quarter total revenue increasing 18% year-over-year to $319.6 million, net income surging 233% to $27.3 million, and Adjusted EBITDA growing 45% to $39.6 million. The company also reaffirmed its 2025 outlook for total revenue growth of 12-13% and net income growth of 30-40%.

• Total Revenue increased 18% year-over-year to $319.6 million, driven by strong performance across all segments.
• Net Income saw a significant jump of 233% year-over-year, reaching $27.3 million.

Orion S.A. reported a decrease in net sales, net income, and EPS for Q1 2025 compared to the prior year, primarily impacted by unplanned plant downtime costs and timing of raw material pass-throughs. Adjusted EBITDA also declined.

• Net sales decreased by $25.2 million year over year to $477.7 million.
• Net income decreased by $17.6 million year over year to $9.1 million.

Energy Recovery's Q1 2025 financial results were in-line with internal expectations, showing a decrease in revenue to $8.1 million due to timing of contracted projects and a net loss of $9.9 million. Gross margin decreased to 55.3%, while operating expenses saw a slight reduction.

• Q1'25 financial results aligned with internal expectations and communicated quarterly revenue cadence for 2025.
• Revenue decreased by $4.0 million compared to Q1'2024, totaling $8.1 million, primarily due to the timing of revenue from contracted projects.

SITE Centers Corp. announced its operating results for the first quarter ended March 31, 2025, reporting a net income attributable to common shareholders of $3.1 million, a significant improvement from a net loss in the prior year. The company highlighted strong demand for its open-air shopping centers and ongoing efforts to maximize asset value through leasing and potential sales.

• Net income attributable to common shareholders increased to $3.1 million ($0.06 per diluted share) in Q1 2025, up from a net loss of $26.3 million ($0.51 per diluted share) in Q1 2024.
• Operating FFO attributable to common shareholders was $8.3 million ($0.16 per diluted share) in Q1 2025, compared to $59.8 million ($1.14 per diluted share) in Q1 2024, primarily due to the spin-off of Curbline Properties.

Evolus reported global net revenue of $68.5 million for Q1 2025, a 15.5% increase year-over-year, driven by strong Jeuveau® demand and market share gains. The company launched Evolysse™ in the U.S. in Q2 and remains on track to achieve positive non-GAAP operating income for the full year 2025.

• Global net revenue for Q1 2025 was $68.5 million, an increase of 15.5% from Q1 2024.
• GAAP operating loss for the first quarter was $15.2 million.

OppFi delivered a strong Q1 2025 with record highs in both total revenue and adjusted net income, driven by improved credit performance and operational efficiency.

• Total revenue reached a record $140,268,000, up 10.1% year-over-year.
• Adjusted net income hit a record $33,817,000, up 285.1% from the previous year.

ProAssurance reported a net loss in Q1 2025, impacted by non-operating items, but saw improvement in non-GAAP operating income and combined ratio. Premium rate increases continued in Specialty P&C, with stable net premiums written for the Medical Professional Liability business.

• Net loss of $5.8 million reported for Q1 2025, primarily due to non-operating items totaling $12.6 million.
• Non-GAAP operating income improved significantly to $6.8 million compared to $3.0 million in Q1 2024.

ADTRAN Holdings, Inc. announced preliminary unaudited financial results for Q1 2025, with revenue reaching $247.7 million, a 10% increase year-over-year. The company reported a GAAP diluted loss per share of $0.13 and non-GAAP diluted earnings per share of $0.03. Gross margin improved to 38.5% GAAP and 42.6% non-GAAP, with robust cash generation from operations.

• Revenue for Q1 2025 was $247.7 million, a 10% increase compared to the same period last year, and exceeded the mid-point of the outlook.
• GAAP gross margin was 38.5%, and non-GAAP gross margin was 42.6%, indicating improved profitability.

Ceva delivered Q1 2025 revenue growth driven by strong licensing gains and powered device shipments, but faced lower royalty revenue and a GAAP net loss; non-GAAP profitability was achieved.

• Total revenue increased to $24,200,000, up 10% year-over-year driven by licensing growth. :contentReference[oaicite:0]{index=0}
• Licensing and related revenue grew to $15,000,000 while royalty revenue declined to $9,200,000 versus the prior year. :contentReference[oaicite:1]{index=1}

Montrose Environmental Group reported strong first quarter 2025 results with record revenue, Consolidated Adjusted EBITDA, and operating cash flow. The company increased its full-year 2025 Adjusted EBITDA guidance and announced a stock repurchase program, demonstrating confidence in its performance and commitment to shareholder value.

• Achieved highest-ever first quarter revenue of $177.8 million, a 14.5% increase year-over-year.
• Reported highest-ever first quarter Consolidated Adjusted EBITDA of $19.0 million, up 12.5% from the prior year.

Ferroglobe reported a challenging first quarter of 2025 with sales decreasing by 16.4% quarter-over-quarter and 21.6% year-over-year to $307.2 million. The company posted a net loss of $66.5 million and adjusted EBITDA of $(26.8) million, reflecting an uncertain market environment and lower pricing. Despite this, Ferroglobe generated positive free cash flow of $5.1 million and maintained a strong balance sheet with no net debt.

• Adjusted EBITDA was $(26.8) million, a significant decrease from the prior quarter and prior year, primarily due to lower pricing and higher energy costs.
• The company generated $5.1 million in free cash flow, which was used to pay increased dividends and repurchase shares.

Gladstone Commercial reported a decrease in net income and Core FFO available to common stockholders and Non-controlling OP Unitholders for the first quarter of 2025 compared to the previous quarter. The decrease in Core FFO was primarily due to a higher net incentive fee. The company continued its capital recycling program by acquiring and selling properties and maintained strong rent collection.

• Total operating revenue for the first quarter of 2025 was $37.5 million, a slight increase from the previous quarter.
• Net income available to common stockholders and Non-controlling OP Unitholders decreased to $1.9 million, or $0.04 per share.

Avadel Pharmaceuticals plc announced robust financial results for the first quarter ended March 31, 2025, with net product revenue from LUMRYZ sales reaching $52.5 million, a 93% increase year-over-year. The company added 300 patients on LUMRYZ during the quarter, bringing the total to 2,800. Following a favorable Federal Circuit decision, Avadel is now able to pursue FDA approval for LUMRYZ in Idiopathic Hypersomnia (IH) and other indications. The company also raised its full-year 2025 guidance for net product revenue and cash flow.

• Net product revenue from LUMRYZ sales increased by 93% to $52.5 million in Q1 2025 compared to Q1 2024.
• The number of patients on LUMRYZ reached 2,800 as of March 31, 2025, a 100% year-over-year increase and 300 new patients added in the quarter.

Excelerate Energy reported strong first quarter 2025 results with significant increases in net income and Adjusted EBITDA compared to both the previous quarter and the prior year. The company also raised its full-year 2025 Adjusted EBITDA guidance and announced a strategic acquisition in Jamaica.

• Reported Net Income of $52.1 million for the first quarter.
• Reported Adjusted EBITDA of $100.4 million for the first quarter.

The ODP Corporation reported a total revenue of $1.7 billion for the first quarter of 2025, a 9% decrease from the prior year. The company experienced a GAAP operating loss of $32 million and a net loss of $29 million. However, adjusted EBITDA was $76 million and adjusted free cash flow significantly increased to $45 million, reflecting improved operational discipline and cash conversion.

• Total reported sales for Q1 2025 were $1.7 billion, down 9% compared to the prior year, primarily due to fewer retail locations and reduced consumer traffic in the Office Depot Division, and lower demand in the ODP Business Solutions Division.
• GAAP operating loss was $32 million and net loss from continuing operations was $29 million, or $(0.97) per diluted share, impacted by $86 million in charges, including $48 million for restructuring expenses.

Pagaya Technologies Ltd. announced strong financial results for the first quarter of 2025, with record Adjusted EBITDA and total revenue. The company achieved GAAP profitability earlier than anticipated, driven by revenue growth and operational efficiencies.

• Net income attributable to Pagaya shareholders reached $8 million, a significant increase of $29 million year-over-year.
• Adjusted EBITDA hit a record $80 million, doubling from the prior year.

Hippo reported strong top-line growth in Q1 2025, with revenue increasing 30% year-over-year, driven by significant growth in their Insurance-as-a-Service segment. However, net loss increased due to the impact of the Los Angeles wildfires, which significantly affected loss ratios. The company also highlighted improving operating leverage and a strong financial position, including a pending $50 million surplus note.

• Revenue increased 30% year-over-year to $110 million.
• Insurance-as-a-Service revenue grew 91% year-over-year.

Conduent had a good start to 2025, with results in line with internal expectations and consistent with its 2025 outlook, despite broad uncertainty in the macro-economic landscape. Adjusted EBITDA margins exceeded expectations, and new business signings and Net ARR Activity Metric improved year-over-year.

• Revenue and Adjusted Revenue were $751 million.
• Pre-tax Income (Loss) was $(56) million.

A-Mark Precious Metals experienced a challenging fiscal third quarter of 2025, reporting a net loss of $8.5 million compared to a net income in the prior year. This was primarily attributed to volatile market conditions, including concerns around tariffs, which led to trading losses and higher interest expenses, as well as one-time acquisition-related costs and a remeasurement loss. Despite these headwinds, the company saw an increase in revenue and gross profit, driven partly by strategic acquisitions that expanded its market position and reach into higher-margin segments.

• Revenue increased by 15% to $3.009 billion in Q3 FY 2025 compared to the same period last year.
• The company reported a net loss attributable to the Company of $8.5 million, a significant decrease from the $5.0 million net income in Q3 FY 2024.

Teekay Corporation Ltd. reported GAAP net income attributable to shareholders of $14.9 million, or $0.17 per share, for the first quarter of 2025. The company declared a one-time special cash dividend of $1.00 per common share, payable in July 2025, and repurchased $4.2 million worth of its outstanding common shares.

• GAAP net income attributable to shareholders of Teekay was $14.9 million, or $0.17 per share, in Q1 2025.
• Teekay declared a one-time special cash dividend of $1.00 per common share, payable in July 2025.

Genco Shipping & Trading Limited reported a net loss of $11.9 million for the first quarter of 2025, or $0.28 basic and diluted net loss per share. This compares to a net income of $18.8 million in the same period last year. Revenues decreased to $71.3 million from $117.4 million in Q1 2024, primarily due to lower rates and a smaller fleet. The company declared a dividend of $0.15 per share for Q1 2025 and announced a new $50 million share repurchase program.

• Genco reported a net loss of $11.9 million for Q1 2025, a significant decline from a net income of $18.8 million in Q1 2024.
• Voyage revenues decreased to $71.3 million in Q1 2025, down from $117.4 million in the prior year, primarily due to lower rates and a smaller fleet.

The Honest Company achieved a solid start to 2025, with revenue increasing by 13% to $97 million, gross margin expanding to 39%, and net income reaching $3 million, reflecting continued strength in strategy and execution.

• Revenue increased 13% to $97 million from the prior year quarter.
• Gross margin expanded 170 basis points to 38.7%.

Emergent BioSolutions reported a 26% decrease in total revenues to $222.2 million for Q1 2025 compared to Q1 2024, but net income surged by 656% to $68.0 million. The company's gross margin expanded to 50%, and adjusted EBITDA increased by 16% to $77.6 million, demonstrating improved profitability despite lower sales.

• Total revenues decreased by 26% to $222.2 million in Q1 2025 compared to Q1 2024.
• Net income increased by 656% to $68.0 million in Q1 2025 compared to Q1 2024.

Intermex reported first-quarter 2025 revenues of $144.3 million, with net income of $7.8 million and diluted EPS of $0.25. Adjusted diluted EPS was $0.35, and adjusted EBITDA was $21.6 million. Despite a challenging economic and political backdrop, the company saw year-over-year volume growth of 3.7%, reflecting the resilience of its consumer base and effective omnichannel strategy.

• Revenues for Q1 2025 were $144.3 million, a decrease of 4.1% year-over-year.
• Net income for Q1 2025 was $7.8 million, a decrease of 35.5% year-over-year.

GCM Grosvenor reported a GAAP net income of $0.5 million for the first quarter of 2025. The company also saw significant increases in fundraising, fee-related earnings, and adjusted net income compared to the previous year.

• Quarter-to-date fundraising increased by 77% year-over-year.
• GAAP Net Income for the quarter was $0.5 million.

OrthoPediatrics delivered a strong first quarter 2025 performance, with total revenue increasing 17% year-over-year to $52.4 million. The company also improved its adjusted EBITDA and reduced free cash flow usage, while expanding its scoliosis portfolio with a new system launch.

• Total revenue for Q1 2025 increased 17% to $52.4 million compared to Q1 2024.
• Adjusted EBITDA improved to a loss of $0.4 million in Q1 2025 from a loss of $1.1 million in Q1 2024.

Groupon, Inc. reported a net income of $7.556 million for Q1 2025, a significant improvement from a net loss of $11.506 million in the prior year period. Diluted EPS stood at $0.17. The company's total revenue for the quarter was $117.187 million, with North America contributing $91.113 million and International contributing $26.074 million.

• Net income improved significantly to $7.556 million from a loss of $11.506 million in the prior year.
• Diluted EPS for continuing operations was $0.18, a positive shift from -$0.33 in the prior year.

Riley Permian delivered a capital-efficient quarter with strong performance, generating substantial Total Free Cash Flow and reducing debt. The company also announced an agreement to acquire Silverback Exploration for $142 million in cash, adding significant undeveloped locations and production.

• Averaged 24.4 MBoe/d of total equivalent production, with oil production at 15.6 MBbls/d.
• Generated $50 million of operating cash flow and $36 million of Total Free Cash Flow.

Cerence reported strong results for Q2 FY25, exceeding the high end of its revenue and adjusted EBITDA guidance. The company achieved its fourth consecutive quarter of positive free cash flow and saw significant year-over-year improvements in revenue, profitability, and gross margin. Full-year guidance was reiterated for revenue and raised for profitability and cash flow.

• Reported revenue of $78.0 million and Adjusted EBITDA of $29.5 million, surpassing the high end of guidance.
• Achieved the fourth consecutive quarter of positive free cash flow, totaling $13.1 million.

Farmland Partners Inc. reported strong first quarter 2025 results with increased net income and raised fiscal year 2025 guidance. The company's strategy of optimizing operations, strategic dispositions, stock buybacks, and the stability of farmland assets contributed to strong shareholder returns, aided by increased interest income, reduced interest expense, and revenue from a solar power arrangement.

• Net income increased significantly to $2.1 million in Q1 2025 compared to $1.4 million in Q1 2024.
• Diluted EPS increased to $0.03 in Q1 2025 compared to $0.01 in Q1 2024.

Global Medical REIT Inc. reported increased net income for the first quarter of 2025 compared to the prior year period, reaching $2.1 million. Rental revenue saw a slight decrease, while total expenses also declined. The company completed the acquisition of a five-property medical portfolio for $69.6 million and disposed of two medical facilities for $8.2 million. The company reaffirmed its full year 2025 AFFO guidance.

• Net income attributable to common stockholders increased to $2.1 million, or $0.03 per diluted share.
• Completed the acquisition of a five-property medical portfolio for $69.6 million at a 9.0% cap rate.

Mativ reported a net loss of $425.5 million for the first quarter of 2025, primarily due to a non-cash goodwill impairment charge of $411.9 million. Sales decreased by 3.1% year over year to $484.8 million. Adjusted EBITDA was $37.2 million, down 19% from the prior year.

• Sales decreased 3.1% year over year to $484.8 million.
• GAAP loss was $425.5 million, heavily impacted by a $411.9 million goodwill impairment charge.

B&G Foods experienced a decline in net sales and gross profit in Q1 2025 compared to the previous year, primarily due to decreased volume, net pricing, and product mix. Despite this, the company reported a significant increase in net income and operating income, largely due to the absence of the goodwill impairment charges that impacted the prior year. Adjusted EBITDA also saw a decrease.

• Net sales decreased by 10.5% to $425.4 million, primarily due to lower volume, net pricing, and product mix.
• Gross profit declined to $90.1 million, or 21.2% of net sales, from $108.9 million, or 22.9% of net sales, in the prior year.

Compass Minerals reported a significant increase in revenue for the second quarter of fiscal 2025, reaching $494.6 million, up from $364.0 million in the prior year. Despite the revenue growth, the company reported a net loss of $32.0 million, an improvement from the $38.9 million net loss in the same quarter last year. Adjusted net earnings were $25.7 million, or $0.63 per diluted share, compared to $74.2 million, or $1.78 per diluted share, in the prior year.

• Revenue increased by 35.9% year-over-year to $494.6 million.
• Net loss improved to $32.0 million from $38.9 million in the prior year.

Cross Country Healthcare reported first quarter 2025 financial results with consolidated revenue of $293.4 million, a decrease of 23% year-over-year. The company posted a net loss of $0.5 million and adjusted EPS of $0.06. Despite the overall revenue decline, Homecare Staffing, Physician Staffing, and Cross Country Education segments experienced growth. The company maintained a strong balance sheet with $80.7 million in cash and no debt, while continuing to work towards the pending merger with Aya Healthcare.

• Consolidated revenue was $293.4 million, a decrease of 23% year-over-year.
• The company reported a net loss attributable to common stockholders of $0.5 million and adjusted EPS of $0.06.

Consensus Cloud Solutions, Inc. reported a slight revenue decrease of 1.1% to $87.1 million in Q1 2025 compared to Q1 2024, primarily due to a planned decline in the SoHo business, partially offset by growth in the Corporate business. Net income decreased to $21.2 million, mainly due to a debt extinguishment loss and changes in foreign exchange revaluation. Despite these factors, the company maintained strong operating margins and cash flows, reaffirming its full-year 2025 guidance.

• Q1 2025 revenues decreased by $1.0 million (1.1%) to $87.1 million, primarily due to a planned decrease in the SoHo business.
• Net income for Q1 2025 was $21.2 million, down from $26.4 million in Q1 2024, influenced by a debt extinguishment loss.

Claros Mortgage Trust, Inc. experienced a net loss of $78.6 million in Q1 2025, a significant increase from the $52.8 million net loss in Q1 2024. Total net revenue decreased by $15.5 million, primarily due to lower revenue from real estate owned and a decrease in net interest income. The company's loan portfolio value decreased, and it recorded a substantial valuation adjustment for loan receivable held-for-sale.

• Net loss increased to $78.6 million in Q1 2025 from $52.8 million in Q1 2024.
• Total net revenue decreased by $15.5 million, driven by lower real estate owned revenue and net interest income.

Invesco Mortgage Capital Inc. reported a net income of $16.3 million and earnings per common share of $0.26 for Q1 2025. Earnings available for distribution per common share were $0.64. The company's investment portfolio primarily consisted of Agency RMBS and Agency CMBS, with a debt-to-equity ratio of 7.1x.

• Net income per common share increased to $0.26 in Q1 2025 from a net loss of $0.09 in Q4 2024.
• Earnings available for distribution per common share rose to $0.64 in Q1 2025 from $0.53 in Q4 2024.

Hain Celestial reported a disappointing fiscal third quarter with net sales down 11% year-over-year and a significant net loss of $135 million, primarily due to worse-than-expected performance in North America and non-cash impairment charges. Despite the overall decline, the international segment showed a return to organic net sales growth.

• Net sales decreased by 11% year-over-year to $390 million.
• The company reported a net loss of $135 million, significantly higher than the $48 million net loss in the prior year period, due to $133 million in pre-tax non-cash impairment charges.

EyePoint Pharmaceuticals reported a significant increase in total net revenue for Q1 2025, primarily driven by deferred revenue recognition from the out-license of YUTIQ US rights. The company continues to make strong progress in its Phase 3 wet AMD clinical trials for DURAVYU, with enrollment exceeding expectations, reinforcing confidence in enrollment completion in 2H 2025 and a first-to-market advantage. Despite increased operating expenses due to clinical trial costs, the company maintains a strong cash position, providing a runway into 2027.

• Total net revenue for Q1 2025 was $24.5 million, a substantial increase from $11.7 million in Q1 2024.
• Enrollment in DURAVYU Phase 3 wet AMD clinical trials (LUGANO and LUCIA) is exceeding expectations, with over 90% of patients randomized into LUGANO and over 50% into LUCIA, reinforcing confidence in 2H 2025 enrollment completion.

Greenlight Capital Re reported a net income of $29.6 million for Q1 2025, an increase of $2.6 million over Q1 2024. This was primarily due to strong performance from its investment in Solasglas and favorable foreign exchange movement, partially offset by an underwriting loss and lower investment-related income from Lloyd’s syndicates.

• Net income increased by $2.6 million to $29.6 million, primarily due to strong investment performance.
• Total investment income increased by $9.1 million, driven by a 7.2% net return from investment in Solasglas.

SkyWater Technology reported total revenue of $61.3 million for Q1 2025, a 23% decrease year-over-year. The company achieved a GAAP gross profit of $14.3 million and a net loss of $7.3 million. Non-GAAP diluted EPS was $(0.08).

• Total revenue for Q1 2025 was $61.3 million, a 23% decrease compared to Q1 2024.
• Wafer Services revenue showed strong sequential growth, driven by demand for the new ThermaView platform.

Hudson Pacific Properties reported a decrease in total revenue and a wider net loss in the first quarter of 2025 compared to the previous year, primarily due to asset sales and lower office occupancy. Despite this, the company saw its best office leasing quarter in nearly three years and increased its leasing pipeline.

• Total revenue decreased to $198.5 million from $214.0 million in Q1 2024.
• Net loss attributable to common stockholders widened to $74.7 million ($0.53 per diluted share) from $52.2 million ($0.37 per diluted share) in Q1 2024.

Ardmore Shipping Corporation reported net income attributable to common stockholders of $5.6 million for the first quarter of 2025, a significant decrease from $38.4 million in the prior year. Revenue also decreased to $74.0 million from $106.3 million. The company declared a cash dividend of $0.05 per common share.

• Net income attributable to common stockholders decreased to $5.6 million in Q1 2025 from $38.4 million in Q1 2024.
• Revenue for Q1 2025 was $74.0 million, down from $106.3 million in Q1 2024.

Bandwidth Inc. announced strong financial results for the first quarter ended March 31, 2025, with revenue of $174.241 million and a net loss of $3.740 million. The company exceeded its guidance for both revenue and profitability, leading to an increased full-year outlook.

• First quarter revenue reached $174.241 million, surpassing guidance.
• Adjusted EBITDA increased by approximately 40% year-over-year to $22.213 million.

AerSale's first quarter 2025 results showed a significant decrease in total revenue to $65.8 million, down 27.4% from the prior year, mainly driven by fewer whole asset sales. The company reported a GAAP net loss of $5.3 million, compared to a net income of $6.3 million in the same period last year. Despite the overall decline, revenue excluding flight equipment sales increased by 23.4%, indicating strong commercial demand for Used Serviceable Material and AerSafe™ products.

• Total revenue for Q1 2025 was $65.8 million, a 27.4% decrease from $90.5 million in Q1 2024.
• GAAP net loss was $5.3 million in Q1 2025, a significant shift from a GAAP net income of $6.3 million in Q1 2024.

Enhabit reported net service revenue of $259.9 million and net income attributable to Enhabit, Inc. of $17.8 million for Q1 2025. Adjusted EBITDA was $26.6 million, and adjusted diluted EPS was $0.10. The company highlighted sequential home health census growth, year-over-year hospice census growth, and improved leverage ratio.

• Net service revenue was $259.9 million in Q1 2025.
• Net income attributable to Enhabit, Inc. was $17.8 million for the quarter.

Dine Brands Global, Inc. reported total revenues of $214.8 million for the first quarter of 2025, an increase from $206.2 million in the prior year, primarily due to the acquisition of 47 Applebee's restaurants. However, net income available to common stockholders decreased to $7.8 million from $17.0 million, and adjusted EBITDA declined to $54.7 million from $60.8 million. Both Applebee's and IHOP experienced declines in domestic comparable same-restaurant sales.

• Total revenues increased to $214.8 million in Q1 2025, up from $206.2 million in Q1 2024, mainly due to the acquisition of 47 Applebee's restaurants.
• Net income available to common stockholders decreased significantly to $7.8 million ($0.53 per diluted share) in Q1 2025, compared to $17.0 million ($1.13 per diluted share) in Q1 2024.

Xperi Inc. reported first quarter 2025 revenue of $114.0 million and a GAAP net loss of $18.4 million. Despite a slight decrease in revenue year-over-year, the company achieved a 200% year-over-year adjusted EBITDA growth, reaching $16.4 million, driven by business transformation efforts and cost reductions. The TiVo One platform expanded its footprint to 2.5 million monthly active users.

• Achieved 2.5 million TiVo One Monthly Active Users, consistent with expectations, setting a foundation for future monetization.
• Reported a 200% year-over-year Adjusted EBITDA growth, reaching $16.4 million, attributed to business transformation and cost savings.

Matrix Service Company reported a significant increase in revenue for the third quarter of fiscal 2025, reaching $200.2 million, up 21% year-over-year. The company achieved break-even Adjusted EBITDA and reduced its net loss per share, driven by strong project execution and backlog growth.

• Total backlog increased by 7.7% from the previous quarter to $1.4 billion.
• Total project awards for the quarter were $301.2 million, resulting in a book-to-bill ratio of 1.5x.

MaxCyte reported a total revenue of $10.4 million for the first quarter of 2025, an 8% decrease compared to the same period in 2024. However, core business revenue increased by 1% to $8.2 million. The company added one new SPL client, TG Therapeutics, bringing the total number of active SPLs to 29. Net loss for the quarter was $10.3 million.

• Total revenue for Q1 2025 was $10.4 million, an 8% decrease from Q1 2024.
• Core business revenue increased by 1% to $8.2 million in Q1 2025.

Ceragon Networks reported Q1 2025 revenues of $88.7 million, a slight increase of 0.2% year-over-year. The company posted a GAAP net loss of $1.0 million and a GAAP operating loss of $1.1 million, impacted by non-recurring restructuring and acquisition-related charges. Non-GAAP results showed a net income of $2.6 million and an operating profit of $4.5 million.

• Revenues for Q1 2025 were $88.7 million, a 0.2% increase compared to Q1 2024.
• The company reported a GAAP net loss of $1.0 million, or ($0.01) per diluted share, and a non-GAAP net income of $2.6 million, or $0.03 per diluted share.

Allient Inc. experienced a decline in financial performance for the first quarter of 2025, with revenues decreasing by 9% to $132,803,000 and net income falling by 48% to $3,557,000 compared to the prior year. This was largely attributed to lower sales volume, particularly in the Vehicle and Industrial markets, and a foreign currency decrease. Despite the revenue and net income decline, the company saw a 13% increase in bookings, reflecting a return to more normalized customer order patterns.

• Revenues decreased by 9% to $132,803,000, primarily due to lower sales volume in Vehicle and Industrial markets and a 1.2% foreign currency decrease.
• Net income significantly decreased by 48% to $3,557,000, impacted by lower sales volume and organic revenue, partially offset by reduced operating expenses.

Health Catalyst exceeded its quarterly guidance on both total revenue and Adjusted EBITDA in Q1 2025. The company reported total revenue of $79.4 million, a 6% increase year-over-year, and Adjusted EBITDA of $6.3 million, an 86% increase year-over-year. Net loss increased by 15% to $23.7 million.

• Total revenue for Q1 2025 was $79.4 million, a 6% increase compared to Q1 2024.
• Adjusted EBITDA for Q1 2025 was $6.3 million, an 86% increase compared to Q1 2024.

NVE Corporation experienced a decline in its financial performance for the fiscal year ended March 31, 2025, with total revenue decreasing by 13.2% and net income decreasing by 12.0% compared to the prior year. This was primarily due to a 15.7% decrease in product sales, although contract research and development revenue saw a significant 112.0% increase. Gross profit margin improved to 83.6%, but total expenses rose by 25.1% due to increased research and development and selling, general, and administrative activities.

• Total revenue decreased by 13.2% to $25,874,694 in fiscal 2025, primarily due to a 15.7% decrease in product sales.
• Net income decreased by 12.0% to $15,064,516 in fiscal 2025 compared to the prior year.

MasterCraft Boat Holdings, Inc. announced its fiscal third quarter 2025 results, with net sales of $76.0 million, down 9.5% from the prior-year period. Income from continuing operations was $3.8 million, or $0.23 per diluted share. The company reported cash and investments of $66.5 million with no outstanding debt.

• Net sales for the third quarter were $76.0 million, a decrease of 9.5% from the comparable prior-year period.
• Income from continuing operations was $3.8 million, or $0.23 per diluted share.

Ares Commercial Real Estate Corporation reported a net income of $9.345 million for the first quarter of 2025, a significant improvement from a net loss of $12.323 million in the same period last year. This turnaround was primarily influenced by a reversal of current expected credit losses, which contributed positively to earnings, despite a decrease in total revenue.

• Net income attributable to common stockholders was $9.345 million, a substantial improvement from a loss of $12.323 million in Q1 2024.
• Total revenue for Q1 2025 was $14.948 million, down from $18.692 million in Q1 2024.

Backblaze achieved a 15% year-over-year revenue increase to $34.6 million in Q1 2025, driven by a 23% growth in B2 Cloud Storage revenue. The company also reported improved gross profit and adjusted EBITDA, indicating enhanced operational efficiency.

• Total revenue increased by 15% year-over-year to $34.6 million.
• B2 Cloud Storage revenue grew by 23% year-over-year, reaching $18.0 million.

OraSure Technologies reported a significant decrease in total net revenues for Q1 2025, down 45% year-over-year, primarily driven by a 98% decline in COVID-19 revenues. Core business revenues saw a slight decrease of 2%. The company experienced increased GAAP and non-GAAP operating losses and net losses compared to the prior year.

• Total net revenues decreased by 45% to $29.9 million in Q1 2025 compared to $54.1 million in Q1 2024, mainly due to lower COVID-19 revenues.
• Core business revenues, excluding COVID-19 and Molecular Services, were $29.5 million, a 2% decrease year-over-year.

TriplePoint Venture Growth BDC Corp. reported a net increase in net assets of $12.7 million, or $0.32 per share, for the first quarter of 2025. The company funded $27.7 million in debt investments with a 13.3% weighted average annualized yield at origination and achieved a 14.4% weighted average annualized portfolio yield on debt investments for the quarter. Net investment income was $10.7 million, or $0.27 per share.

• Net increase in net assets resulting from operations was $12.7 million, or $0.32 per share.
• Net investment income was $10.7 million, or $0.27 per share.

Chicago Atlantic Real Estate Finance, Inc. reported a net income of $10,041,312 for the first quarter of 2025, an increase of 15% from the $8,730,003 reported in the first quarter of 2024. Total expenses decreased by 33% to $3,000,621, primarily due to a significant benefit from current expected credit losses. EPS remained consistent at $0.48.

• Net income increased by 15% to $10,041,312 in Q1 2025 compared to Q1 2024.
• Total expenses decreased by 33% due to a benefit from current expected credit losses.

eHealth delivered a strong first quarter, with total revenue increasing by 22% year-over-year, driven by significant Medicare segment growth and positive net adjustment revenue. The company also saw substantial improvements in net income and adjusted EBITDA, alongside strong operating cash flow.

• Total revenue increased 22% year-over-year to $113.1 million.
• Medicare Advantage submissions grew 25% year-over-year.

CS Disco reported a 3% increase in total revenue year-over-year for the first quarter of 2025, reaching $36.7 million. The company's net loss for the quarter was $11.4 million.

• Total revenue for Q1 2025 was $36.7 million, a 3% increase compared to Q1 2024.
• Net loss attributable to common stockholders was $11.4 million for Q1 2025.

Potbelly Corporation delivered a strong first quarter in 2025, with total revenues increasing by 2.3% to $113.7 million and a substantial improvement in net loss, which decreased from $2.8 million in the prior year to $62 thousand. The company also reported positive system-wide sales growth and continued progress in its franchise development efforts.

• Total revenues increased by 2.3% to $113.7 million in Q1 2025.
• GAAP net loss attributable to Potbelly Corporation significantly improved to $62 thousand from $2.8 million in Q1 2024.

ON24 reported total revenue of $34.7 million for Q1 2025, with a GAAP net loss of $8.7 million and a non-GAAP net loss of $0.4 million. The company achieved its 5th consecutive quarter of positive operating and free cash flow and initiated a new $50 million share repurchase program.

• Achieved total revenue of $34.7 million.
• Recorded 5th consecutive quarter of positive operating and free cash flow.

Velan Inc. delivered a robust performance in the first quarter of fiscal 2025, with sales increasing by 14.5% to $77.5 million and gross profit rising significantly to $23.8 million, representing a 30.7% gross margin. The company reduced its net loss to $1.1 million from $8.3 million in the prior year and ended the quarter with a strong order backlog of $528.3 million.

• Sales increased by 14.5% year-over-year to $77.5 million.
• Gross profit significantly improved to $23.8 million, with gross margin reaching 30.7%.

Inogen reported stronger financial results in the first quarter of 2025 compared to the prior year, driven by increased international and domestic business-to-business sales. This growth was partially offset by declines in direct-to-consumer sales and rental revenue. The company saw improvements in gross margin, operating expense, and net loss, and achieved positive adjusted EBITDA.

• Total revenue increased by 5.5% to $82.3 million in Q1 2025.
• GAAP net loss improved significantly to $6.2 million from $14.6 million in the prior year.

Beyond Meat experienced a challenging first quarter in 2025 with a 9.1% decrease in net revenues to $68.7 million, primarily due to weak category demand in the U.S. retail and foodservice channels. The company reported a gross loss of $1.1 million and an increased operating loss of $56.2 million, impacted by strategic charges and legal fees. Despite the revenue decline, operating expenses were reduced year-over-year. The company also secured $100 million in new senior secured financing as part of efforts to strengthen its balance sheet.

• Net revenues decreased by 9.1% year-over-year to $68.7 million.
• Gross profit was a loss of $1.1 million, resulting in a gross margin of -1.5%.

Hudson Technologies reported a decline in first-quarter 2025 revenue and profitability due to lower refrigerant market pricing, despite a slight increase in sales volume. The company maintained a strong balance sheet with $81 million in cash and no debt.

• First quarter 2025 revenue was $55.3 million, a 15% decrease from the prior year.
• Gross margin compressed to 22% in Q1 2025, down from 33% in Q1 2024, primarily due to price changes.

Vanda Pharmaceuticals reported total net product sales of $50.0 million for the first quarter of 2025, a 5% increase from the previous year. The company experienced a net loss of $29.5 million, reflecting expenses related to a new license agreement and increased commercial activities. Fanapt showed significant growth with a 14% increase in total prescriptions and net product sales.

• Total net product sales increased by 5% to $50.0 million in Q1 2025 compared to Q1 2024.
• Fanapt net product sales grew by 14% to $23.5 million in Q1 2025, with new to brand prescriptions increasing nearly threefold.

Cryoport, Inc. announced its first quarter 2025 financial results, reporting total revenue from continuing operations of $41.0 million, a 10% increase year-over-year. The company saw significant growth in its Life Sciences Services segment, up 17% year-over-year, and a stabilization in its Life Sciences Products business. Adjusted EBITDA showed meaningful improvement, reducing the negative figure from $6.7 million in Q1 2024 to $2.8 million in Q1 2025. A strategic partnership with DHL Group, including the divestiture of CRYOPDP, is expected to enhance operational reach and competitive profile.

• Total revenue from continuing operations for Q1 2025 was $41.0 million, an increase of 10% year-over-year.
• Commercial Cell & Gene therapy revenue increased by 33% year-over-year, contributing to the 17% growth in Life Sciences Services revenue.